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Abstract 
Transcription and translation (TX-TL) can be performed in vitro, outside of cells, allowing the assembly and analysis of 
genetic networks. This approach to engineering biological networks in a less complex and more controllable 
environment could one day allow rapid prototyping of network designs before implementing them in living cells. 
Furthermore, the in vitro approach provides insight into how natural biological systems are built and is instructive to 
define the rules for engineering biological systems from bottom up. 
Despite progress in engineering TX-TL mixes for higher yields and longer synthesis times it remains challenging to 
implement complex genetic networks, such as oscillators, in vitro. The reason is that the reactions are usually performed 
in a batch format, where reaction products accumulate and synthesis rates decline over time. 
We addressed the problems associated with batch reactions by developing a microfluidic chip with nanoliter-scale 
reactors that exchange reagents at dilution rates matching those of dividing bacteria. In these nano-reactors we can run 
TX-TL reactions in continuous mode keeping synthesis rates at constant steady state levels for more than 30h. The 
setup allows close control over the reaction conditions such as dilution rates and DNA template concentration, and to 
monitor mRNA and reporter protein levels in real time. We can test genetic programs of our choice just by adding the 
DNA templates coding for the desired functions. We implemented diverse regulatory mechanisms on the transcriptional, 
translational, and posttranslational levels, including RNA polymerases, transcriptional repression, translational 
activation, and proteolysis.  
As a proof of concept for this reactor-based approach to engineering genetic networks we designed and implemented a 
novel genetic oscillator. Its network architecture consists of a positive feedback loop coupled to delayed negative 
feedback. Varying dilution rates and DNA template concentrations we mapped its phase diagram showing that steady 
state conditions were necessary to produce oscillations. The period of oscillations could be tuned by dilution rate. 
To demonstrate that in vitro synthetic biology is useful for prototyping of dynamic genetic networks, we compared the 
behavior of biomolecular ring oscillators in a cell-free framework and Escherichia coli. Our cell-free framework 
combines an E. coli lysate TX-TL system with the nano-reactor device. We implemented and characterized the 
“repressilator”, a three-node negative feedback oscillator in vitro. We then used our cell-free framework to engineer 
novel three-node, four-node, and five-node negative feedback architectures going from the characterization of circuit 
components to the rapid analysis of complete networks. We validated our cell-free approach by transferring the three-
node and five-node oscillators to E. coli, resulting in robust and synchronized oscillations reflecting our in vitro 
observations. Our results demonstrate that comprehensive circuit characterization can be rapidly performed in a cell-
free system and that these in vitro results have direct applicability in vivo. 
Enabling a quantitative and more complete characterization of synthetic and natural networks, the reactor-based 
approach to in vitro synthetic biology developed in this thesis will be useful to speed up design-build-test cycles in 
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genetic circuit design. Furthermore it can be useful to assemble and test subsystems of a future synthetic cell and to 
explore whether fundamental limits exist to in vitro network complexity. 
 
Keywords 
Cell-free transcription and translation, In vitro synthetic biology, Genetic networks, Oscillators, Microfluidics, 
Fluorescent mRNA probes 
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Zusammenfassung 
Transkriptions- und Translationsprozesse können aus Zellen isoliert ablaufen. Dieses In-vitro Verfahren erlaubt die 
Analyse von genetischen Netzwerken in Reaktionsgefäßen unter weniger komplexen und besser kontrollierbaren 
Bedingungen, wo es eines Tages Forschern erlauben könnte Netzwerkprototypen zu testen, bevor diese in Zellen 
eingebracht werden. Außerdem bieten in-vitro Verfahren einen Einblick in den Aufbau von natürlichen biologischen 
Systemen und können zu Erkenntnissen beitragen, wie biologische Systeme aus isolierten Molekülen aufgebaut werden 
könnten. 
Trotz Fortschritten bei der Entwicklung von In-vitro-Translationssystemen, die höhere Ausbeuten und längere 
Synthesezeiten erlauben, ist es noch immer schwierig komplexe genetische Netzwerke, wie Oszillatoren, in diesen In-
vitro-Systemen zu untersuchen. Der Grund dafür ist, dass die Reaktionen meist in einem diskontinuierlichen Prozess 
durchgeführt werden, wobei sich Reaktionsprodukte ansammeln und Syntheseraten abnehmen. 
Um dieses Problem zu lösen haben wir einen miniaturisierten Durchfluss-Reaktor-Chip entwickelt, in dem die In-vitro-
Translations-Reagenzien mit Flussraten ausgetauscht werden, die den Verdünnungsraten in sich teilenden Bakterien 
entsprechen. In diesen Nanoreaktoren können wir Transkriptions- und Translationsreaktionen über 30 Stunden lang 
unter kontinuierlichen Bedingungen durchführen, welche die Syntheseraten in einem Fließgleichgewicht halten. Dabei 
erlaubt uns der mikrofluidische Chip die Reaktionsbedingungen genau zu kontrollieren, zum Beispiel die 
Verdünnungsrate und die Konzentration der Template-DNA. Zudem können wir über Fluoreszenzmikroskopie die 
Konzentrationen von mRNA und Reporterproteinen in Echtzeit bestimmen. In diesem System können wir genetische 
Programme unserer Wahl testen indem wir die Template-DNA hinzufügen, auf der die gewünschten Funktionen kodiert 
sind. So konnten wir verschiedene regulatorische Mechanismen untersuchen, die auf unterschiedlichen Ebenen wirkten. 
RNA-Polymerasen und Repressorproteine steuerten die Transkription, die Translation konnte mit Hilfe von 
regulatorischen RNA-Molekülen reguliert werden und posttranslational konnten wir durch gezielte Proteindegradation 
die Lebensdauer von Proteinen verändern. 
Um zu zeigen, dass unser Reaktor für die Charakterisierung von dynamischen genetischen Netzwerken nützlich ist, 
implementierten wir einen neuartigen genetischen Oszillator. Seine Netzwerkstruktur bestand aus einer positiven 
Rückkopplung die wir mit einer verzögerten negativen Rückkopplung verknüpften. Wir untersuchten das 
Phasendiagramm des Oszillators, indem wir Template-DNA-Konzentrationen und Verdünnungsraten veränderten. 
Dabei konnten wir zeigen, dass kontinuierliche Reaktionsbedingungen notwendig waren um Oszillationen zu 
beobachten. Die Geschwindigkeit der Oszillationen konnte mit Hilfe der Verdünnungsrate eingestellt werden. 
Um einen Nutzen für die Biotechnologie zu haben, müssen In-vitro-Systeme bei der Analyse von biologischen 
Netzwerken relevante Ergebnisse für zelluläre Systeme liefern. Um dieses zu testen untersuchten wir molekulare 
Ringoszillatoren in unserem zellfreien System und in Escherichia coli. Zuerst charakterisierten wir den „Repressilator“, 
ein Oszillatornetzwerk aus drei Repressorproteinen. Daraufhin entwickelten und testeten wir neue zyklische Netzwerke 
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mit drei, vier und fünf Knoten aus weiteren Repressoren, die wir zunächst isoliert charakterisierten. Eine Analyse 
unserer neuen Ringoszillatoren aus drei und fünf Invertern in E. coli, wo diese regelmäßige und synchronisierte 
Oszillationen zeigten, bestätigte unsere in-vitro Beobachtungen. Unsere Ergebnisse zeigen, dass umfassende Analysen 
von genetischen Netzwerken in zellfreien Systemen möglich sind und dass deren Ergebnisse direkte Relevanz für 
zelluläre Systeme haben. 
In-vitro-Systeme erlauben quantitative und vollständigere Analysen von synthetischen und natürlichen Netzwerken. Der 
Reaktor-basierte Ansatz für die in-vitro Analyse von biologischen Netzwerken, der in dieser Arbeit entwickelt wurde, 
wird von Nutzen für die synthetische Biologie sein um Netzwerkprototypen zu erproben. Außerdem könnte er es 
erlauben die molekularen Grundfunktionen einer zukünftigen künstlichen Zelle aufzubauen und zu testen und zu 
erforschen wo die Grenzen der Komplexität von biologischen Netzwerken außerhalb von Zellen liegen. 
 
Stichwörter 
Zellfreie Transkription und Translation, In-vitro synthetische Biologie, Genetische Netzwerke, Oszillatoren, 
Mikrofluidik, Fluoreszenzmarker für mRNA 
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Chapter 1 Introduction 
1.1 In vitro synthetic biology 
Synthetic biology uses engineering principles to facilitate the creation of novel biological functions and systems. The 
field has been rapidly growing since 15 years when the first artificial genetic devices, the toggle switch1 and the 
repressilator2, were constructed in the bacterium Escherichia coli. Since then, many more potentially useful genetic 
circuits have been built such as switches, oscillators, logic gates, filters, sensors and devices for cell-cell 
communication3. Facilitated by DNA synthesis technologies, progress in parts characterization, standardization and 
modularization, and growing databases of sequences coding for novel biosynthesis pathways and genetic regulators, 
synthetic biology has the potential to have a major impact on human health, energy and the way we interact with our 
environment. However, despite many promising achievements, the complexity of synthetic systems is still far from that 
of natural biological systems and the engineering process remains challenging4. Many parts are not sufficiently well 
characterized, behave unpredictably under changed conditions and depend strongly on their host because of unintended 
interactions with natural cellular processes. Even when parts are well characterized and function reliably separately, 
they often do not behave in the expected way when they are assembled into larger devices or systems requiring 
laborious tweaking of expression strengths to achieve the desired behavior. This not very rational testing and 
construction process can become prohibitively time-consuming and expensive for more complex systems. In silico 
models can help to identify targets that will have the greatest effects on the system’s performance but are often 
incomplete and provide only qualitative insights. Another problem is that functioning of the synthetic circuits is linked 
to viability of their cellular host. Toxicity and loading effects are common and lead to failure of the synthetic circuit or 
unpredictable results 5. In short, many problems of synthetic circuits arise because their cellular hosts are insufficiently 
characterized and interactions are far too complex to be quantitatively modeled. 
In vitro, cell-free systems have the advantage that this complexity is reduced facilitating a thorough and quantitative 
characterization of the system. In fact, a large portion of the knowledge about the molecular mechanisms of processes in 
cells, such as metabolism, replication, transcription and translation derives from biochemistry studies looking at single 
enzymes or larger molecular assemblies in isolation. Similarly, in vitro synthetic biology aims at isolating specific 
biological phenomena of interest or to re-create them from natural or unnatural parts in a test tube. 
This is interesting from a fundamental research point of view because it allows testing if one’s knowledge about the 
necessary components of a system is complete. Examples of this idea include reconstitution of the bacterial Min system 
self-organizing into surface waves on membranes in vitro6 and reconstitution of the bacterial transcription7 and 
translation 8 machineries. In vitro, hypotheses can be tested more rapidly because measurements and perturbations are 
easier in cell-free systems. In vitro systems allow experiments that would be difficult or impossible in vivo as they do 
not require host viability and are not confined in cellular boundaries. For example, the optimization of a metabolic 
network for synthesis of a fine chemical showed how extensive measurements and perturbations can lead to enhanced 
understanding of a system and ultimately to improved yields9. In addition to facilitating measurements and 
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perturbations, in vitro systems can be sufficiently simple to allow complete and quantitative models, for example of the 
transcription and translation reactions10,11, and of dynamic reaction networks 12-15. Re-creating systems from unnatural 
building blocks can provide insights on how the architecture of a network influences system behavior un-obscured by 
the specific properties of the natural components. Examples for this included implementation of a genetic network 
emulating embryonic pattern formation in an artificial spatially structured environment16, predator-prey dynamics re-
created from a DNA-based reaction network14 and the study of genetic regulatory networks by constructing oscillators 
and switches in simplified environments, which will be discussed in more detail below. 
One ambitious long-term goal of in vitro synthetic biology is to assemble an artificial cell-like structure from the 
bottom-up using well-characterized building blocks, which would be a major advance in elucidating the fundamental 
mechanisms of life. As progress in this direction many studies have shown interactions between cytoskeletal proteins 
and membranes, which may be harnessed to reconstitute a division machinery of an artificial cell. For example, the 
bacterial Min system self-organizes on membranes 6, actin bundles could be anchored to the membranes of vesicles 17, 
contractile FtsZ rings were reconstituted in liposomes 18, and microtubules and molecular motors induce shape changes 
of lipid vesicles 19. Although a combination of all fundamental processes an artificial cell would need to perform20 is 
still far out of reach, progress has been made towards reconstituting other sub-systems like DNA replication21, the 
transcription7 and translation machinery8, and a simple metabolism22.  
Although a well-understood cell-like hybrid of biological and synthetic materials might have applications for 
interfacing between living and non-living materials, as a biosensor, for therapeutics or synthesis of biopolymers 20,23, in 
vitro systems also have other, more immediate applications. They can, for example, be used to synthesize fine 
chemicals that are difficult to produce synthetically 24-27. They can also be used to produce proteins that are difficult to 
produce in living cells such as proteins that contain non-natural amino acids28 or that are medically relevant 29,30 or 
libraries of proteins for screening purposes31,32. Recently, in vitro systems have also begun to attract attention for rapid 
prototyping of genetic parts33,34, simple genetic networks35 and metabolic pathways9 for in vivo implementation. 
1.2 Genetic networks in vitro 
In vitro systems provide a simplified environment to study genetic networks, which allows analysis of network 
architectures and parameter spaces that give rise to certain dynamic phenomena. Of interest are for example bistable 
switches and molecular memory, sensory systems such as fold-change detectors, and networks that generate spatial 
patterns or oscillations. These phenomena are interesting from a purely theoretical point of view and because they are 
important in biology. Bistability for example allows switching between states in the life cycle of the phage lambda, in 
the E. coli lac operon and in cell cycle progression36. Fold-change detection can be found in the molecular mechanism 
for bacterial chemotaxis37. Pattern formation is important in development 14,38 and oscillating networks control the 
circadian rhythm, cell divisions, signaling and metabolic systems39.  
All the above-mentioned dynamic phenomena have been re-created in biochemically simple in vitro systems relying on 
the synthesis, hybridization and degradation of nucleic acids. The in vitro transcriptional circuits developed by Erik 
Winfree’s group use synthetic DNA molecules that undergo hybridization reactions and can be transcribed into short 
RNA sequences, which then in turn activate or inactivate switches by hybridizing with complementary DNA strands. 
This system has been used to build transcriptional oscillators12,40, a bistable circuit41 and a fold-change detector 37. 
Another, similarly simple system is the DNA toolbox42, which uses DNA hybridization, polymerization and 
degradation reactions to construct dynamic reaction networks generating oscillations13, switchable memories15 and 
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spatio-temporal patterns14,38. The above examples show that these simple, artificial systems based on nucleic acid 
chemistry can be used to study wide varieties of dynamic reaction networks. The reactions are sufficiently simple to 
allow quantitative models and to allow the reactions to remain in a far-from-equilibrium state for hours, allowing 
complex dynamics.  
Despite the advantages of their simplicity purely nucleic acid based systems are too artificial for some questions. For 
more immediate relevance for in vivo systems it is advantageous to study true genetic networks that are based on 
transcription and translation reactions and involve natural genetic regulators. In vitro transcription and translation (TX-
TL) reaction mixes have been developed for cell-free protein synthesis and can produce large amounts of product. 
Depending on the application or the protein of interest one can choose between lysates from different origins (the most 
popular ones are E. coli, wheat germ and rabbit reticulocytes) containing the native biosynthetic machinery of that 
organism43. A different interesting system in the commercially available PURE system, a minimal, defined reaction mix, 
which consists of the reconstituted translation machinery of E. coli8. The PURE system has the advantage that all its 
components and their concentrations are known. This makes it interesting for bottom-up synthetic biology because it is 
not a “black box” unlike a lysate system, which essentially contains all the proteins present in the cytoplasm of the 
strain that was used to prepare the extract. Use of this defined, minimal system also eliminates unwanted side reactions 
that consume energy and precursors. Disadvantages of the PURE system are its rather high cost, lower yields and 
shorter synthesis times compared to many extract systems. For efficient transcription most TX-TL reaction mixes 
contain a phage RNA polymerase but lysates can also be prepared by methods preserving the activity of the native E. 
coli polymerase44, which makes them interesting for in vitro synthetic biology and rapid prototyping33,45. In order to 
achieve transcription from native E. coli promoters in the PURE system it is possible to supplement the reaction with a 
purified E. coli RNA polymerase holoenzyme 7 but this generally results in low transcription rates. Quantitative models 
of the transcription and translation processes exist for both lysate-based systems10 and the PURE system11. 
More than ten years ago, Noireaux and Libchaber built the first cell-free genetic networks 46. Their networks were 
mainly activation cascades, where the output of one stage acted on the expression of the next stage. This study showed 
that it was generally possible to build genetic networks of considerable size (up to three expressed genes) but also 
showed important limitations of the system. The authors observed that each new stage decreased the output by at least 
an order of magnitude and pointed out loading effects on the translational machinery due to the accumulation of 
transcripts46. Other early examples of in vitro genetic networks were a short cascading network in lioposomes47 and a 
simplified network emulating pattern formation in Drosophila development16. Later cell-free genetic networks also 
incorporated specialized genetic control such as RNAi to build a two-input logic gate48. With advances in the 
preparation of efficient TX-TL reagents network sizes became larger 45 but examples of positive and negative feedback 
remained basic. Simple negative feedback was achieved with TetR and LacI repressors reducing their own expression 
and by sigma factor 28 competition for the E. coli RNA polymerase core enzyme 35,45. A simple positive feedback loop 
was constructed from T7 RNA polymerase activating its own transcription49. In vitro genetic networks have been 
limited in circuit size and capabilities in feedback regulation because transcription and translation rates decline over 
time as reaction products accumulate and precursors are consumed. Especially the accumulation of reaction products 
makes it difficult to implement dynamic genetic networks such oscillators and switches that rely on negative feedback 
because regulators from earlier stages in the network will never be removed. In order to increase mRNA and protein 
turnover in TX-TL reactions active degradation mechanisms have been implemented50 and reaction times could be 
increased by placing the reaction in specialized reactors and “feeding” it with precursor molecules 51-55. A continuous 
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reaction would simultaneously solve both problems associated with genetic networks in TX-TL reactions, deceasing 
synthesis rates and accumulation of reaction products, but requires specialized technology. 
1.3 Aims and overview of this thesis 
Motivated by the power of cell-free systems for quantitative and extensive analyses of biological systems we aimed to 
study dynamic genetic networks in vitro. In the beginning of this research project, no dynamic genetic network, such as 
an oscillator, had been implemented in a cell-free environment. This thesis aimed to develop technologies for the 
implementation and quantitative characterization of dynamic genetic networks in vitro, and to demonstrate how these 
tools can be used for basic and applied research.  
Most regulators used to build genetic networks act on the initiation of transcription. Frequently, however, the mRNA 
intermediate of the TX-TL reaction is not determined. For a quantitative understanding and rational engineering of 
genetic networks we needed a method to measure and follow mRNA concentrations during TX-TL reactions. Chapter 2 
describes the development of binary FRET probes and a complementary mRNA target site for real-time measurement 
of mRNA concentrations in vitro. We used this method to characterize transcription and mRNA degradation rates, 
resulting in a quantitative description of mRNA dynamics in the PURE system. 
Chapter 3 describes how we addressed the issues of performing TX-TL reactions in batch format, where reaction 
products accumulate and synthesis rates decline over time. We developed a microfluidic nano-reactor device that 
exchanges reagents at dilution rates matching those of dividing bacteria to keep TX-TL reactions at steady state. I will 
show how we used this reactor-based approach to characterize diverse genetic regulatory mechanisms, and to 
implement the first genetic oscillator in a TX-TL reaction demonstrating that continuous conditions allow the analysis 
of the operating regimes of dynamic genetic networks in vitro. 
To be of significance to biological engineering for the prototyping of genetic networks, it is critical that synthetic 
circuits behave similarly in cells and in cell-free environments. Chapter 4 will describe a cell-free framework for 
biological systems engineering, and demonstrate that genetic networks can be rapidly characterized and engineered in 
vitro with direct relevance for in vivo systems. We characterized the repressilator network2 in vitro and engineered 
novel three-node, four-node, and five-node negative feedback architectures. We then transferred the novel three- and 
five-node oscillators to E. coli, where we observed similar robust oscillations like in the in vitro system showing that 
cell-free synthetic biology has the potential to drastically speed up design-build-test cycles in biological engineering. 
Finally, in chapter 5 I will briefly summarize and discuss the results of this work pointing out limitations and how those 
could be addressed in the future. An outlook will describe possible applications of the technologies developed in this 
thesis. 
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Chapter 2 Real-Time mRNA Measurement during an in Vitro 
Transcription and Translation Reaction Using 
Binary Probes 
Niederholtmeyer H, Xu L, and Maerkl SJ. (2012) ACS Synth. Biol. 2: 411–417. 
 
2.1 Abstract 
In vitro transcription and translation reactions have become popular for a bottom-up approach to synthetic biology. 
Concentrations of the mRNA intermediate are rarely determined although knowledge of synthesis and degradation rates 
could facilitate rational engineering of in vitro systems. We designed binary probes to measure mRNA dynamics during 
cell-free protein synthesis by fluorescence resonance energy transfer. We tested different mRNA variants and show that 
the location and sequence environment of the probe target sites are important parameters for probe association kinetics 
and output signal. Best suited for sensitive real-time quantitation of mRNA was a target site located in the 3’ un-
translated region, which we designed to reduce secondary structure. We used this probe – target pair to refine our 
knowledge of mRNA dynamics in the commercially available PURE cell-free protein synthesis system and 
characterized the effect of TetR repressor on mRNA synthesis rates from a T7 promoter. 
2.2 Introduction 
In vitro transcription and translation (ITT) reactions have been widely used and optimized for protein synthesis and 
screening purposes 31,52. More recently, those in vitro systems have become popular for a bottom-up approach to 
synthetic biology 46. Fundamental molecular processes of life were reconstituted in vitro, such as the E. coli translation 
machinery from purified components 8 and the E. coli RNA polymerase holoenzyme, which was synthesized by adding 
the DNA templates for the subunits of the enzyme complex into an ITT reaction 7. Examples for structural self-
organization that could be reconstituted in ITT reactions programmed with DNA templates include the synthesis and 
assembly of the T7 bacteriophage 56, the self-assembly of cytoskeletal structures in liposomes 57 and emulating 
embryonic pattern formation 16. The dynamics and behavior of synthetic gene networks have also been studied in ITT 
reactions. Multi-stage cascades, where the gene product of one stage is the input for the next stage, AND gates, and 
negative feedback loops have been assembled 35,45-47. All genetic regulators, activators, and repressors, employed in 
these genetic networks acted on the initiation of mRNA synthesis. Furthermore, Shin and Noireaux have established a 
method to increase mRNA turnover and propose that active mRNA degradation might facilitate the engineering of 
dynamic genetic networks 50. Despite their focus on regulation of mRNA synthesis and mRNA degradation these 
studies only used reporter protein production as their readout. To rationally assemble and characterize in vitro genetic 
networks it would be helpful to directly quantitate mRNA dynamics and synthesis rates. After all, it is this intermediate 
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that regulation acts upon most often and whose concentration determines protein output, often in a non-linear fashion as 
the translation machinery becomes saturated at high concentrations of mRNA 46.  
RNA concentrations can be determined by different techniques in vivo and in vitro. Potential real-time methods that can 
detect a specific mRNA employ fluorophores that bind to a region of the mRNA of interest, which changes their 
emission properties. Examples include “spinach” 58 and oligonucleotide probes like molecular beacons and binary 
probes 59,60. Binary probes consist of two DNA oligonucleotides that hybridize to adjacent locations on a target 
sequence. Each carries a fluorophore of a fluorescence resonance energy transfer (FRET) donor – acceptor pair. When 
both probes are bound to the target sequence the fluorophores are brought in close proximity so that FRET can occur. 
This technique has been used to measure mRNA synthesis during in vitro transcription 61. Models of the transcription 
and translation processes during GFP synthesis were important steps towards a more quantitative understanding of the 
dynamics of protein synthesis in cell-free systems 10,11. These studies also measured mRNA levels over time to take into 
account synthesis and degradation of mRNA for their models. Stögbauer et al. 11 used a molecular beacon, which bound 
to a sequence in the GFP coding region on the mRNA. 
In this work we designed binary probes, which we tested in combination with different mRNA target designs in order to 
derive a probe – target pair that allows sensitive real-time quantitation in ITT reactions and could be used for other 
genes without the need for sequence re-design. We demonstrate the value of the probes as a tool for in vitro synthetic 
biology by refining our understanding of RNA dynamics in the PURE ITT system 8 and measuring the effect of the 
TetR repressor on mRNA synthesis from a T7tet promoter. 
2.3 Results and discussion 
We decided to place the probe target site, the nucleotide sequence to which the binary probes bind, outside of the 
protein coding region, either in the 5’ or 3’ un-translated region (UTR), in order to avoid interference between probe 
binding and translating ribosomes. This has the additional advantage that the same probe – target combination could be 
used for other genes without requiring a different set of costly FRET probes and re-optimization of the target sequence. 
Similar to previous probe designs 61,62, we chose a sequence of 30 bp as the target for the two probes, which consisted 
of 15 bp each. We chose Cy3 and Cy5 fluorophores as our FRET pair, with a spacing of 4 nucleotides, or about 1.65 nm, 
for optimal FRET efficiency 59 (Figure 2.1). 
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Figure 2.1 Design of the binary probes and their target sequence.  
(A) Real-time measurement of mRNA during in vitro transcription and translation. A mRNA with the target site for the 
binary probes and the coding region for the protein is produced from a DNA template. The binary probes carrying either 
a Cy3 or Cy5 fluorophore are present in the ITT mix and hybridize to the RNA. This brings the donor and acceptor 
fluorophores in close proximity so that FRET can occur. The FRET fluorescence allows quantification of mRNA 
concentration over time. (B) Sequences of the RNA target (black) and the bound probes with positions of the 
fluorophores. 
 
We found that the sequence environment of the target site on the mRNA has a strong influence on the observed FRET 
signal. We thus synthesized different mRNAs in vitro, purified them and compared binding of the binary probes to 
identical target concentrations. In the different mRNAs tested the probe target site was placed either in the 5’ or the 3’ 
UTR (Figure 2.2a). We tested one mRNA with the target site in the 5’ UTR and three mRNAs with the target site in the 
3’UTR. Those differed in the distance of the target site to the stop codon (3’ target version 1 compared to versions 2 
and 3) and the stability of the secondary structure that could be formed by the nucleotides surrounding the target 
sequence, which was minimized in version 3 by adding stretches of adenines around the target site (see Table S2.1).  
We observed a stable FRET signal over 12h when the probes were added to a DNA target in buffer (Figure 2.2b), 
showing that no photo-bleaching occurred under the imaging conditions employed. All mRNAs, except for the negative 
control without a target sequence, produced measureable FRET signals and EGFP protein, when added to ITT mix 
(Figure 2.2d). The binding kinetics and the maximal FRET signals differed considerably for the different target variants 
tested in both buffer (Figure 2.2b) and ITT mix (Figure 2.2c), which we attribute to mRNA secondary structure and 
degradation. When the target site was located on mRNA, hybridization of the probes was slower than to the DNA target. 
The 5’UTR target gave rise to the slowest binding kinetics and lowest FRET signal. The mRNAs with the target site in 
the 3’UTR exhibited faster association kinetics and higher FRET signals, indicating that mRNA secondary structure and 
target site location are important parameters (see Table S2.1). The fastest binding kinetics and highest FRET signal was 
observed for the 3’UTR with the sequence that was specifically optimized to reduce secondary structure in the 
nucleotides surrounding the 30bp target sequence. It was our goal to have a sensitive real-time measurement of mRNA 
during in vitro protein synthesis, so for all subsequent experiments we used the 3’ UTR version 3. In addition, this 
3’UTR also increased protein production probably by altering the secondary structure of the mRNA (Figure 2.2d, Table 
S2.1). 
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Figure 2.2 Effect of the sequence environment of the target site on hybridization kinetics and FRET signal. 
(A) Schematics of the different DNAs and RNAs that were compared for probe binding. The DNA target was the 30 bp 
complementary sequence to the probes. The mRNAs were produced by in vitro transcription with T7 RNA polymerase 
and all contained the same EGFP coding region and ribosomal binding site (RBS). They differed in the position and the 
sequence around the target site located in the 5’ or 3’ UTR. The colored lines representing the bound probes indicate 
position of the target site. (B,C) Hybridization of the binary probes (each at 1µM) to DNA or mRNA target (all at 480nM) 
in buffer (B) or ITT mix (C). FRET signal was calculated by normalizing the FRET fluorescence to the Cy5 fluorescence 
and subtracting the FRET background from a reaction containing no RNA or DNA (see Methods for details). (D) EGFP 
signal produced by the reaction in (C). 
 
During synthesis of mRNA from the different DNA templates (Figure 2.2a), the 3’ target 3 also gave rise to the highest 
FRET signal when tested in a transcription reaction (Figure S2.1) as well as in an ITT reaction (Figure S2.2). Although 
different concentrations of mRNA were synthesized, these differences could not explain the differences in signal. When 
the FRET signal in a transcription or an ITT reaction was normalized by mRNA concentration, 3’ target 3 showed the 
highest signal (Figures S2.1 and S2.2), which shows that during synthesis of mRNA, probe hybridization kinetics are 
important for sensitivity. When identical concentrations of purified mRNA were added into an ITT reaction we 
observed the same dependence of hybridization kinetics and FRET signal on target site position as in buffer, but here 
the FRET signal declined exponentially after reaching a peak at about 20 min (Figure 2.2c). We attributed this decline 
to mRNA degradation. We verified by qRT-PCR that mRNA degradation was indeed occurring at a comparable rate as 
determined by our FRET probes (Figure 2.3). Degradation of mRNA follows first order kinetics 10,50. This exponential 
decay can be described by the following function: 
(1) , 
where m0 is the initial mRNA concentration and degm the mRNA degradation rate. 
Known amounts of mRNA were added to ITT mix containing an excess amount of binary probes (1µM). The 
decreasing FRET signals of different initial mRNA concentrations (250 to 900 nM, starting at 40 min, see Figure S2.3) 
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were fitted to equation (1) and the RNA degradation rate was determined to be 0.0085 ± 0.0019 min-1, which is 10-fold 
greater than the value reported for the PURE system in a previous study 11, where mRNA degradation had not been 
observed experimentally but was determined by fitting a model with eight free parameters to the experimental data. 
 
Figure 2.3 Degradation of mRNA in the PURE ITT mix. 
Degradation of 500 nM mRNA in ITT mix as observed by qRT-PCR and FRET signal. The experimental results are 
compared to the predicted RNA concentration for a degradation rate of 0.0085 min-1. 
 
In order to calibrate the FRET signal to mRNA concentration we used the peak FRET signal of different mRNA 
concentrations (average of signal from 10 to 30 min) and plotted this against the mRNA concentration at 20 min, which 
was calculated from the known initial concentration and the RNA degradation rate. The FRET signal increased linearly 
with mRNA concentration until mRNA concentration exceeded probe concentration (Figure 2.4). At a probe 
concentration of 1 µM we could detect mRNA concentrations ranging from 50 to 900 nM. At mRNA concentrations 
below 50 nM the signal to noise ratio was too low to allow a reliable quantitation under our experimental conditions. 
 
 
Figure 2.4 Calibration of the FRET signal to mRNA concentration. 
The peak FRET signal around 20 min (average of signal between 10 and 30 min) was plotted against the RNA 
concentration at 20 min, which was calculated from the known initial mRNA concentration using the determined 
degradation rate. For mRNA concentrations smaller than probe concentration (1µM) the FRET signal increased linearly 
with a slope of 0.0035 nM-1. 
 
Using the calibration of the FRET signal we could quantitate mRNA synthesis from a DNA template. The mRNA 
synthesis rate depended on the DNA template concentration used in the ITT reaction (Figure 2.5a). Although the 
mRNA concentrations differed more than threefold over the range of DNA template concentration tested, the effect on 
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EGFP concentration was low, showing that the translation machinery became saturated above 200 nM of mRNA (see 
Figures S2.3b and S2.4b). The mRNA measurement determined from the FRET signal was confirmed by qRT-PCR for 
the highest DNA template concentration (Figure 2.5a). 
The change in mRNA concentration, m, can be described by the following differential equation: 
(2)  
The transcriptional activity, syn(d), is a function of the DNA concentration, d. We assume DNA concentration to be 
constant, which is a fair approximation as the DNA template decays very slowly and retains full functionality until up to 
6h into the ITT reaction (Figure S2.7). The degradation rate of mRNA, degm, we previously determined. With m(0)=0, 
the solution of equation (2) for a given DNA template concentration is: 
(3)   
To determine initial transcription rates the mRNA concentrations of the different DNA template concentrations during 
the first 100 min of the reaction were fitted to equation 3 (Figure S4a) and plotted against DNA concentration (Figure 
2.5b). Transcription can be described by Michaelis-Menten kinetics:  
(4)  
By fitting equation 4 the maximum transcription rate, vmax, was determined to be 10.4 nM/min and the DNA 
concentration for half-maximal transcription rate, KTS, was 4.4 nM (Figure 2.5b). Both values were in good agreement 
with values reported by Stögbauer et al. using the same ITT mix 11. 
To be able to describe the complete reaction, we have to take into account a decrease of transcriptional activity because 
the process consumes substrates and enzymes can degrade. If there was no decrease of transcriptional activity, the 
mRNA concentration would reach a steady state when mRNA synthesis and degradation are balanced (Figure S2.5). 
The fact that mRNA concentration decreases after reaching a maximum at about two to three hours suggests that the 
transcriptional activity decreases. In contrast to Stögbauer et al. 11, we did not observe a clear dependence of the time 
when RNA synthesis ceases on the DNA concentration (Figure 2.5a). At this point we did not want to make any 
assumptions on the mode by which transcriptional activity decreases, so we introduced the relative activity, act(t), as the 
fraction of initial transcriptional activity at time t. 
(5)  
Using Euler’s method mRNA concentration over time can be approximated with: 
(6)  
(7)  
m '(t) = syn(d)! degm "m(t)
m(t) = syn(d)degm
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Using equation 7 and the experimental results for mRNA concentration, we calculated the relative transcriptional 
activity comparing two time points with a fixed time increment of Δt over the course of the ITT reaction (Figure 2.5c). 
For all DNA template concentrations the relative transcriptional activity followed a sigmoidal curve. For the first hour it 
remained at its initial rate and then decreased to 0 after about eight hours (Figure 2.5c, Figure S2.6). Interestingly, the 
transcription rate started to decrease when EGFP synthesis started to plateau. It has been shown that a decrease in 
energy charge caused by the hydrolysis of nucleoside tri- and diphosphates is the limiting factor for cell-free protein 
synthesis reactions 8,46. Translation is the main contributor to this decrease in energy charge 63.Transcription, however, 
also requires nucleoside triphosphates, which could explain why protein and mRNA synthesis cease at the same time. 
The relative mRNA synthesis activities were fitted by a Hill function: 
(8)   
For neither the time of half-maximal activity, thalf, or the Hill coefficient, n, which determines the steepness of the 
activity decline, a dependence on DNA concentration could be observed (Figure S2.6). The average of thalf was 203±13 
min and 2.9±0.7 for n (black line in Figure 2.5c). With this, equation 5 could predict mRNA concentration over the 
complete reaction time of 12 hours for different DNA template concentrations (Figure 2.5d). We also show that the 
decrease in transcriptional activity could not be explained by a degradation of the DNA templates, which degrade at a 
much slower rate (Figure S2.7). 
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Figure 2.5 RNA synthesis from different DNA template concentrations during ITT. 
(A) RNA concentrations during synthesis from different template concentrations in ITT, measured by binary probes and 
qRT-PCR. (B) Initial mRNA synthesis rates for different DNA template concentrations. Initial rates were determined from 
the first 100 min of synthesis assuming no decline of transcriptional activity. (C) Relative transcriptional activity over time 
during synthesis from different DNA template concentrations. Relative activity was determined with equation 7 from the 
concentration change during a time increment of 6 min. To reduce the noise we used the average of 3 measurements 
(corresponding to 6 min) around each time point. With the known mRNA degradation and initial synthesis rate we could 
calculate what fraction of initial activity was left at each time point. The black line is the Hill function (equation 8), which 
was used to fit the results (see Supporting Figure S4). (D) Results of our model of mRNA dynamics in ITT at different 
DNA template concentrations. The model took into account mRNA degradation and a transcription rate, which is 
dependent on the DNA template concentration (B) and time (C). 
 
Regulators in genetic networks often act by modulating transcription. A number of transcriptional activators and 
repressors have been used to build in vitro networks 35,45-47. In ITT reactions their effect has, to our knowledge, only 
been studied as output of a reporter protein product. For a rational design of in vitro networks it would however be 
useful to study the effect on mRNA synthesis directly. We applied our method of real-time mRNA measurement to the 
repression of a T7 promoter by TetR. Instead of the standard T7 promoter used to drive expression in the previous 
experiments, the T7tet promoter included the TetR operator sequence downstream of the T7 promoter. This promoter 
had been previously shown to be repressible by TetR in Leishmania 64. Purified TetR protein was added at different 
concentrations to the ITT reaction and a dependence of mRNA synthesis rate and EGFP output on TetR concentration 
was observed (Figure 2.6 and Figure S2.8). 1000 nM of TetR inhibited transcription almost 5-fold while the control 
reactions with the standard T7 promoter without a TetR binding site remained unaffected (Figure 2.6c). The maximum 
transcription rate synmax (4.9 nM/min), the TetR concentration for half-maximal repression (368 nM), Km, and the Hill 
coefficient (1.2) were determined by fitting a Hill function (Figure 2.6c): 
(9)   
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The Km we observed is substantially higher than the affinity of TetR to its operator, which was determined to be 
5.6nM65. This discrepancy can be explained by the fact that repressor and polymerase do not exclude each other from 
the promoter, as has been found for inhibition of T7 RNA polymerase by the lac repressor bound at a similar distance 
downstream of the promoter 66. Operator placement in respect to the T7 promoter is important for the repression 
characteristics 67,68 and it seems that there is a tradeoff between maximal expression strength and efficient repression 
depending on the distance of the operator to the transcriptional start site 35. With the first base of the tet operator at +9 
relative to the T7 promoter we measured an intermediate Km of about 370 nM in respect to the values determined by 
Karig et al. 35, which were 73 nM for the operator starting at +4 and 3000 nM for the operator starting at +10. We would 
like to stress however that Karig et al. determined repression via protein output, which might have masked a repression 
of transcription rate in the case of the latter, stronger promoter due to saturation of the translational machinery with 
mRNA. We observed this effect for EGFP output (Figure 2.5d), where half-maximal repression is obtained at a higher 
TetR concentration (845 nM). 
For a thorough characterization of genetic parts and devices in ITT reactions it will be useful to determine transcription 
rates directly and in real-time. In this regard the 3’ UTR target – binary probe pair we described in this work will be a 
useful tool for in vitro synthetic biology to quantitate mRNA concentrations in ITT reactions. Our probe - target pair 
has been optimized for fast binding kinetics to provide sensitive real-time measurements and can be used for other 
genes of interest. It could also be useful for in vitro transcriptional circuits, where a number of different RNA molecules 
are synthesized 12. We applied the method to refine our knowledge of mRNA dynamics in the PURE system, where we 
found that mRNA degradation plays a more important role than had been previously suggested 11 and we characterized 
the repression of a T7tet promoter 64 by TetR in the same cell-free protein synthesis kit. 
 
Figure 2.6 Repression of transcription from the T7tet promoter by TetR. 
Examples of mRNA (A) and EGFP (B) synthesis driven by the T7tet promoter at different concentrations of TetR 
repressor. DNA template concentration was 10 nM. (C) Initial mRNA synthesis rates versus TetR concentration for the 
T7tet promoter and the constitutive T7 promoter control. (D) Endpoint EGFP signals for T7tet and constitutive T7 promoter 
at different TetR concentrations. The RNA synthesis rates and final EGFP signal of the repressed promoter were fitted to 
a Hill function (equation 9) to determine maximal activity, concentration of TetR for half-maximal activity and Hill 
coefficient. 
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2.4 Methods 
DNA linear template preparation and sequences 
DNA templates for ITT or in vitro RNA synthesis reactions were prepared by two-step PCR 69.. The EGFP coding 
region was amplified from pKT127 70 with gene specific primers, which also introduced a strong ribosomal binding site. 
T7 promoter and terminator, as well as the respective 5’ and 3’ UTRs, which contained the target sites were added in 
the second step of the PCR by the 3’ and 5’ extension primers (see Supporting Table S2.2). PCR products were purified 
before use and concentrations determined with a Nanodrop spectrophotometer. Oligonucleotides used as primers and 
the binary probes were purchased from IDT DNA. The binary probes had the following sequences: 5’-
/Cy3/ACCAATGGGCTCAGT-3’ and 5’-GAGTCCTTCC/Cy5/ACGAT-3’. 
Reaction setup and RNA and EGFP measurements  
RNA and DNA targets were tested in Buffer 4 (New England Biolabs) supplemented with 200µg/ml BSA and 1µM 
probes. For ITT reactions the commercial kit PURExpress (New England Biolabs) was used following the 
manufacturers instructions. Reactions were supplemented with Protector RNase Inhibitor (Roche), 1µM of each probe, 
DNA or mRNA and TetR repressor (obtained from Imgen Biosciences Inc.) at the indicated concentrations. Reaction 
volume was 5µl, which was centrifuged to the bottom of wells in optical 384-well polystyrene plates (Nunc) and 
covered with 35µl of Chill-Out Liquid wax (Biorad) to avoid evaporation. Reactions were performed at 37°C in a 
Biotek SynergyMx plate reader at 37°C without shaking. Every 2min for 12 hours EGFP fluorescence (excitation 
485±9nm, emission 515±9nm at a sensitivity of 70), Cy5 fluorescence (650±9nm, 680±9nm, sensitivity 100) and 
Cy3/Cy5 FRET fluorescence (540±20nm, 680±20nm, sensitivity 100) were measured. Fluorescence of technical repeats 
varied substantially due to the small reaction volume. We found that we could significantly reduce this variability by 
normalizing to the Cy5 fluorescence, which is unaffected from probe binding. EGFP and FRET signals were 
determined by dividing with Cy5 fluorescence of the respective well. For FRET signals we additionally subtracted the 
background fluorescence of a reaction that contained water instead of DNA or mRNA template over time. EGFP signal 
was calibrated to known concentrations of purified protein (BioVison) (Figure S2.9). 
Preparation of pure mRNA and qRT-PCR 
RNA was prepared with the MEGAscript T7 kit (Ambion) and purified with the MEGAclear kit (Ambion) following 
the manufacturers instructions. Concentrations were determined spectrophotometrically. As a control, mRNA 
concentrations during ITT reactions were measured by qRT-PCR. For this, 1µl samples were taken at different time 
points from a tube containing ITT mix at 37°C and diluted 50-fold in H2O. These samples were stored at -80°C until 
used. If necessary a DNase treatment was performed using the TURBO DNA-free kit (Life Technologies). Afterwards 
the samples were further diluted to a final dilution of 1:10,000. 2µl of sample were analyzed in 10µl reactions of the 
Power SYBR Green RNA-to-CT 1-Step kit (Life Technologies) in the 7500 Fast Real-Time PCR System (Applied 
Biosystems). Primers amplified a region of the EGFP gene (see Table S2.2) and were used at 0.6µM for the forward 
and at 0.3µM for the reverse primer. These conditions resulted in PCR efficiencies between 96 and 98%. 
Concentrations were determined from a standard curve of dilutions of purified mRNA synthesized from the T7-EGFP 3’ 
target version 3 template in a range from 0.3 to 36.3pM mRNA per PCR reaction. 
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2.5 Supplementary Information 
 
 
Table S2.1: Secondary structure and position of target site. Distance to ribosomal binding site (for 
5’ target) or stop codon (for 3’ targets). Stability of mRNA secondary structure was calculated for the 
sequence surrounding the target site (± 35 bp) using mfold71 (http://mfold.rna.albany.edu/?q=mfold/RNA-
Folding-Form) with default settings. If multiple structures were possible, the free energies, ΔG, of all of 
them are listed. The FRET signals in buffer (main text Figure 2b) were fitted with the exponential 
saturation function f(x) = S(1−e−bx). The observed association rate, b, and the FRET signal at saturation, 
S, are listed. 
mRNA ΔG (kcal/mol) Distance Association rate 
(min-1) 
FRET signal at 
saturation 
5’ target -25.0, -24.0 56 bp 0.02 1.4 
3’ target 1 -16.7 46 bp 0.09 1.6 
3’ target 2 -17.1 62 bp 0.09 1.9 
3’ target 3 -5.1, -4.9 62 bp 0.34 2.2 
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Table S2.2: Oligonucleotide primers used in the study. 
 
Use and primer name Sequence 
EGFP gene specific PCR: 
EGFP-fwd CCTCTAGAAATAATTTTGTTTAACTTAAGAAGGAGGAAAAAAAA
ATGTCTAAAGGTGAAGAATTATTCAC 
EGFP-rev GTAGCAGCCTGAGTCGTTATTATTTGTACAATTCATCCATACCAT
GG 
5’ extension primers: 
5’ext-T7_no-tgt GATCTTAAGGCTAGAGTACTAATACGACTCACTATAGGGAGACC
ACAACGGTTTCCCTCTAGAAATAATTTTGTTTAAC 
5’ext-T7_5’tgt GATCTTAAGGCTAGAGTACTAATACGACTCACTATAGGGAGACC
ACAACGGTTTCACTGAGCCCATTGGTATCGTGGAAGGACTCGCC
TGTTTTCGCTTGTGTAGAGTTCTTCCTCTAGAAATAATTTTGTTT
AAC 
5’ext-T7tet GATCTTAAGGCTAGAGTACTAATACGACTCACTATAGGGAGATC
TCCCTATCAGTGATAGACCTCTAGAAATAATTTTGTTTAAC 
3’ extension primers:  
3’ext_no-tgt CAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGGGTTATG
CTAGTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTGTAGCAGCCTGAG
TCG 
3’ext_3’tgt-1 CAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGGGTTATG
CTAGTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTGATCGAGTCCTTC
CACGATACCAATGGGCTCAGTAAGAACTCTACACAAGCGAAAA
CAGGCGTAGCAGCCTGAGTCG 
3’ext_3’tgt-2 CAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGGGTTATG
CTAGTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTGATCGAGTCCTTC
CACGATACCAATGGGCTCAGTAAGAACTCTACACAAGCGAAAC
TGACATCTGGAGTACACAGGCGTAGCAGCCTGAGTCG 
3’ext_3’tgt-3 CAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGGGTTATG
CTAGTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTGATAGAGTCCTTC
CACGATACCAATGGGCTCAGTTTTTTGTTTTTTGGGTTTTGGTTT
TGTTTTCCAGTACACAGGCGTAGCAGCCTGAGTCG 
Final amplification primers: 
5’final GATCTTAAGGCTAGAGTAC 
3’final CAAAAAACCCCTCAAGAC  
qRT-PCR:  
EGFP-qPCR-fwd GGTGAAGGTGAAGGTGATGC 
EGFP-qPCR-rev TAAGGTTGGCCATGGAACTG 
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Figure S2.1: Comparison of FRET signal during mRNA synthesis of mRNAs with different target 
sites in a transcription reaction. Despite RNA concentration differences, 3’ target 3 was most sensitive 
also in a transcription reaction. (A) FRET signal over time. (B) RNA concentration determined by 
quantification from a gel. Lanes 1-5 are the different time points in the graph. The ladder is a DNA ladder 
and cannot be used to estimate the size of the RNA molecules. 1µl of a 1:10 dilution of the reaction was 
loaded on the gel. DNA template was present at a concentration of 18.5nM in the reactions and was not 
visible on the gel. Transcription reactions were performed in 40mM Tris-HCl pH 7.9, 6mM MgCl2, 10mM 
DTT, 10mM NaCl, 2mM spermidine, 2mM NTPs and with 1:100 of T7RNAP enzyme mix of the 
MEGAscript kit (Ambion). The gel was prepared as described in 72 and stained with GelRed (Biotium). (C) 
FRET signal normalized by RNA concentration determined in (B). Shown is on the left the normalized 
FRET signal over time and on the left the averages of all time points with their standard deviation. 3’ 
target 3 has the highest FRET signal per mRNA molecule. 
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Figure S2.2: Comparison of FRET signal during mRNA synthesis of mRNAs with different target 
sites in an ITT reaction. Despite RNA concentration differences, 3’ target 3 was most sensitive during 
RNA synthesis in an ITT reaction. (A) FRET signal over time. (B) RNA concentration determined by 
qRT-PCR. Reactions were performed at a DNA template concentration of 18.5nM. FRET signal of the 3’ 
target 3 mRNA was higher than the signal from the other target mRNAs to an extend, which cannot be 
explained by their differences in concentration. (C) FRET signal normalized by RNA concentration 
determined in (B). 3’ target 3 has the highest FRET signal per mRNA molecule. The normalized FRET 
signals varied over time, which is could be due to hybridization kinetics or the fact that qRT-PCR 
primers were located in the middle of the mRNA, while the FRET target is at the 3’ or 5’ end of the 
mRNA, where the mRNA is probably degraded earlier. 
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Figure S2.3: Addition of different concentrations of pure mRNA with 3’ target version 3 into ITT 
mix. (A) FRET signals. The traces of the concentrations between 250 and 900 nM, starting at 40 min, 
were fitted to a function of exponential decay to determine the mRNA degradation rate. (B) Final EGFP 
signal reached in the reactions in (A). 
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Figure S2.4: RNA and EGFP synthesis from different DNA template concentrations. (A) Initial RNA 
synthesis rate was determined by fitting RNA concentration during the first 100 min of the reaction to 
equation 3 (see main text). (B) Final EGFP signal reached in the reactions in (A) from different DNA 
template concentrations. 
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Figure S2.5: Degradation of transcriptional activity. (A) Comparison of mRNA concentration predicted 
from our model for an mRNA degradation rate of 0.0085 min-1 and a constant transcriptional activity 
(values shown in Figure 5b) to experimental results for different DNA concentrations. (B) Differences 
between experimental results and the prediction for constant transcription rates (A). For all DNA template 
concentrations there is a significant difference starting after 120 min. 
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Figure S2.6: Relative transcriptional activity over time in ITT reactions containing different DNA 
template concentrations. (A) Summary of fit results for different template concentrations. We found no 
dependence on DNA template concentration. (B-F) Fraction of initial mRNA synthesis rate left at each 
time point of the reactions containing different DNA template concentrations calculated as described in 
the main text. Shown is also the fit to the Hill function in (A). 
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Figure S2.7: DNA stability in an ITT reaction. 18.5nM of DNA template were incubated at 37°C in an 
ITT reaction. Samples were taken at different time points and analyzed by different methods. (A) DNA 
template was labeled on both ends with a Cy5 fluorophore, which was introduced by the final primers. 
For each time point, 1µl of ITT mix was run on a gel and imaged on a Typhoon Scanner (GE) for Cy5 
fluorescence. The intensity of the bands was analyzed. The graph shows the average band intensities 
of 3 replicates. This method overestimates DNA degradation because the DNA template is still 
functional if some terminal bases are missing. (B) DNA concentration in ITT mix was also measured by 
qRT-PCR, which amplified a 90bp region in the EGFP coding region. This method underestimates DNA 
degradation because only a short stretch of template from the middle of the molecule has to be present 
to produce a signal. (C) For a functional test of DNA stability, a DNA template with the 3’ target 3 and a 
T3 promoter instead of the T7 promoter, which is not transcribed by the T7 RNA polymerase in the ITT 
reaction, was used. Subsequently, 1µl of a 1:2 dilution of the samples was added to a 5µl ITT reaction 
containing 200nM T3 RNA polymerase. The reaction for time point 0 therefore contained 1.85nM of 
DNA template. Initial RNA synthesis rate and final EGFP concentration were determined as described in 
the main text. In combination the experiments show that DNA is degraded starting at the ends of the 
molecule. The functional test shows that the promoter and the 3’ target are hardly affected by 
degradation until 6h. 
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Figure S2.8: Model predictions of mRNA synthesis from TetR repressed T7 promoter at different 
TetR concentrations. Initial mRNA synthesis rates given by Figure 6C were used in the model 
presented in Figure 5 to predict mRNA concentration over time in an ITT reaction containing different 
concentrations of TetR repressor. 
 
 
 
 
 
 
 
 
Figure S2.9: Calibration of EGFP fluorescence signal to EGFP concentration. Different 
concentrations of purified EGFP protein (BioVision) were added to ITT reactions and imaged under 
standard conditions. 
  
350
300
250
200
150
100
50
0
7006005004003002001000
TetR (nM):
 0
 5
 50 
 100
 200
 500
 800
 1000
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
43210
 37 
Chapter 3 Implementation of cell-free biological networks at 
steady state 
Niederholtmeyer H, Stepanova V, and Maerkl SJ. (2013) Proc. Natl. Acad. Sci. USA 110: 15985–15990. 
 
3.1 Abstract 
Living cells maintain a steady state of biochemical reaction rates by exchanging energy and matter with the 
environment. These exchanges usually do not occur in in vitro systems, which consequently go to chemical equilibrium. 
This in turn has severely constrained the complexity of biological networks that can be implemented in vitro. We 
developed nanoliter-scale microfluidic reactors that exchange reagents at dilution rates matching those of dividing 
bacteria. In these reactors we achieved transcription and translation at steady state for 30 hours and implemented 
diverse regulatory mechanisms on the transcriptional, translational, and post-translational level, including RNA 
polymerases, transcriptional repression, translational activation, and proteolysis. We constructed and implemented an in 
vitro genetic oscillator and mapped its phase diagram showing that steady state conditions were necessary to produce 
oscillations. This reactor-based approach will allow testing whether fundamental limits exist to in vitro network 
complexity. 
3.2 Significance 
Transcription and translation can be performed in vitro, outside of cells, allowing the assembly of artificial genetic 
networks. This bottom-up approach to engineering biological networks in a completely defined and minimal 
environment is instructive to define the rules and limitations of network construction. It is, however, still challenging to 
implement complex genetic networks in vitro because the reactions are usually performed in a batch format, where 
reaction products accumulate and synthesis rates decline over time. Here, we addressed this problem by developing a 
microfluidic device to perform in vitro transcription and translation reactions in continuous mode, where synthesis rates 
stay constant. This allowed us to build and implement a genetic oscillator that showed sustained oscillations for 
extended periods of times. 
3.3 Introduction 
Instead of complex and ill-characterized cellular hosts, in vitro systems have recently become popular alternatives for 
implementing synthetic networks. In vitro systems can be completely defined, easily manipulated, interrogated, and 
have been used to study a number of biological phenomena. For example, periodic temporal patterns were observed in 
systems based on nucleic acid synthesis and degradation 12,13, and ordered spatial patterns were created from purified 
cell division regulators 6. In vitro transcription and translation (ITT) based systems should, in principle, be able to 
employ all regulatory functionalities found in living cells. Reconstituted, defined ITT systems like the PURE mix 8, are 
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particularly appealing for bottom-up synthetic biology. A number of recent examples show that various genetic 16,35,45-47 
and metabolic 22 networks can be implemented in ITT systems. Complexity of genetic networks has, however, been 
limited to genetic cascades, where the output of one stage acts on the next stage, while examples of positive and 
negative feedback have been basic 35,45,49. The main limitation to network complexity in vitro derives from its batch 
reaction format. In batch, synthesis rates decrease as pre-cursors are consumed, enzymatic activities degrade, and 
reaction products accumulate. This rapid approach to chemical equilibrium severely limits network size. In addition, 
negative feedback is particularly difficult to implement, because regulators from earlier stages are not removed. Partial 
solutions to these problems included systems that supplied small molecule precursors by diffusion 45,55, implementation 
of active degradation mechanisms for RNA and proteins 50, or the use of simpler biochemical systems that consume less 
energy and can therefore run for a longer time 12,13. 
3.4 Results 
Steady state transcription and translation in microfluidic nano-reactors 
To enable the implementation of complex genetic networks in vitro we developed a microfluidic device in which ITT 
proceeds at steady state for extended periods of time. Our microfluidic device contains eight independent 33nL reactors 
(SOM), and functions similarly to previous devices 73-75. Dilutions occurred in discrete steps, where each dilution step 
added fresh ITT mix and template DNA, displacing part of the old reaction volume (Figure 3.1A). Dilution rates could 
be precisely tuned by changing the volume displaced per dilution step in a range of 10-40% of reactor volume. The time 
interval between dilution steps was kept at 15min (SOM). These exchanges resulted in dilution rates of 0.4-2 h-1. To 
enable long-term reactions, we cooled the ITT mix off-chip to 6°C, while keeping the on-chip reaction temperature at 
37°C. Fluorescent reporters allowed us to determine DNA, mRNA, and protein concentrations in real-time 76 and a 
computer program controlled all device and imaging operations (Figure 3.1B, Section 3.7) 
We used a reaction rate model to describe the process of transcription and translation 10,11,76. We measured the reaction 
rate parameters that characterize an ITT batch reaction, and added the dilution steps that replace fractions of the reactor 
volume by reaction mix with full synthesis activity (Figure 3.1C and Section 3.8). During continuous reaction, synthesis 
rates reach a steady state, where the rate at which activity decrease is balanced by the inflow rate of fresh reaction mix. 
Consequently, RNA and protein concentrations also reach steady-state levels (Figure 3.1D). On the basis of our model 
(see Supplementary Information), a genetic system like the repressilator 2 would not oscillate in a batch reaction. 
Improvements like degradation mechanisms for mRNA and protein, as well as elongated synthesis times 45,50,55 could 
possibly lead to a few damped oscillations in batch, whereas sustained oscillations can only be obtained under 
continuous conditions (Figure 3.1E).  
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Figure 3.1 ITT under steady state conditions. 
(A) Function of a microfluidic nano-reactor for continuous ITT. At each dilution step, the supply channel is flushed with 
fresh reagent. A peristaltic pump meters a specific volume into the reaction ring. After both ITT mix and DNA have been 
added, another peristaltic pump mixes the reaction. (B) Experimental setup and analysis. (C) Model of EGFP synthesis 
in the reactor. Relative transcriptional (TX) and translational (TL) activities decrease at constant rates. In the continuous 
reaction (blue arrows), all modeled species are diluted at a constant rate, and DNA as well as relative TX and TL 
activities are replaced at the same rate. (D) Model predictions for a batch and a continuous reaction. Predictions were for 
18.3nM DNA and dilutions of 32% every 15min. (E) Model of the repressilator2 under three reaction conditions (SOM). 
We show the concentration of one of the repressor proteins, R. 
 
We performed protein synthesis reactions in vitro, generating EGFP from a linear DNA template regulated by a T7 
promoter at dilution rates comparable to bacterial doubling times between 20 and 104min (Figure 3.2A). We achieved 
dilution dependent steady state mRNA and protein levels for 30h (Figure 3.2B). Independent of dilution rate, DNA 
template concentration remained constant in all conditions (Figure S3.1). When we momentarily stopped the flow of 
fresh reagents, RNA and protein concentrations increased, and returned to their previous steady state levels when 
dilution was resumed (Figure 3.2C). To demonstrate the dynamic nature of synthesis and dilution we switched between 
periods where DNA template or water was added (Figure 3.2D). This led to continuously changing DNA template 
concentrations with RNA and protein concentrations oscillating with a slight delay. Our model accurately captured 
these dynamic changes. 
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Figure 3.2 Steady state ITT. 
(A) Dilution conditions for the experiments in this figure. Experimental RNA and protein concentrations (solid lines, left 
axes) and model prediction (dashed lines, right axes) for (B) long-term ITT at different dilution rates, (C) a transient 
switch to batch conditions and (D) oscillating DNA template concentrations (shaded area: water added; white area: DNA 
added). 
 
 
Implementation of regulatory mechanisms 
We implemented a number of regulators, acting transcriptionally, translationally, and post-translationally, under steady 
state conditions. We transiently expressed the regulators to allow comparison of RNA and protein concentration of the 
reporter in the presence and absence of the regulator in one experiment (Figure 3.3). We implemented transcriptional 
activation by expressing T3 RNA polymerase (T3RNAP) or sigma factor 70 (σ70) in the presence of the Escherichia 
coli RNAP core enzyme, and EGFP under control of their respective promoters. Expression of either protein increased 
RNA concentration from undetectable levels to ~150 and 18nM for T3RNAP and E. coli RNAP, respectively, and also 
increased EGFP concentration in the expected manner (Figure 3.3A). Transcriptional repression by TetR reduced 
transcription of promoters expressed by three different polymerases (T3, T7, and E. coli RNAP). Co-expression of tetR 
reduced RNA levels to 30, 50 and 40% of their unrepressed levels for T3, T7 and E. coli RNAP, respectively. These 
changes of mRNA concentration consequently led to a decrease in EGFP levels (Figure 3.3B). We implemented 
translational activation using two regulator RNAs that were previously used in vivo to induce mRNA translation by 
trans-activation and stop codon suppression (Figure 3.3C) 77,78. In trans-activation a trans-activator RNA modifies 
mRNA secondary structure of a cis-repressed RNA making the ribosomal binding site accessible 77. For stop codon 
suppression we used the amber suppressor tRNA encoded by supD allowing read-through of a UAG stop codon 78, 
which was located immediately after the start codon of the EGFP gene. Aminoacylation of the tRNA with serine 
required no additives to the ITT system as both enzyme and amino acid are present. These mechanisms led to an 
increase in EGFP concentration from undetectable levels to 14 and 35nM, while RNA concentrations remained high in 
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the presence and absence of the regulator RNA (expression of supD reduced RNA concentration by about 10-20%, 
Figure 3.3B). To quantify the effect of both activators on translation of their respective reporter mRNAs, which were 
synthesized at different concentrations, we used the model of EGFP ITT to determine the ratio of observed to expected 
EGFP concentration for the measured mRNA concentration. According to this analysis, translation efficiency was 1.4% 
for trans-activation and 2.8% for stop codon suppression (Figure S3.2). Finally, we successfully implemented protein 
degradation by reconstituting the AAA+ protease ClpXP (a large 700-800kDa multisubunit complex 79). Degradation of 
GFP targeted for recognition by AAA+ proteases has been shown in cell extracts, where these proteases were naturally 
present 50. Here, we functionally expressed the protease in vitro expressing from two separate DNA templates for the 
two subunits of the protease and showed that it specifically degraded ssrA tagged EGFP. In the presence of ClpXP 
steady state EGFPssrA concentration decreased by about 80% (Figure 3.3D). Again, we calculated expected EGFP 
concentrations from the measured mRNA concentrations, which decreased when ClpX and ClpP were expressed, to 
determine if EGFP decrease was indeed caused by protein degradation. Only in the case of ssrA-tagged EGFP did we 
observe a significant decrease of observed to expected EGFP when both protease subunits were expressed (Figure 
S3.2). 
 
 
 
Figure 3.3 Regulation at the transcriptional, translational, and post-translational level. 
Solid lines: experimental data, dashed lines: controls. DNA template of the regulator was transiently present (grey 
shaded area, concentration calculated for dilution rate set in the nano-reactor experiment). Reporter (EGFP) DNA 
template was present at constant concentration. Detailed summary of concentrations and controls in table S2. (A) 
Transcriptional activation by T3RNAP and σ70. E. coli RNAP core enzyme was present in the reaction mix. Controls: 
wrong activator. (B) Transcriptional repression by TetR. Promoters transcribed by three different RNA polymerases were 
tested in the presence of their respective polymerase. Controls: promoter without repressor binding site. (C) Activation of 
translation by RNA molecules. Controls: wrong activator. (D) Protein degradation by ClpXP protease. Controls: no 
degradation tag (ssrA): grey lines; only one protease subunit expressed: broken lines.  
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An in vitro genetic oscillator 
Using three regulators from this toolbox we built a genetic oscillator based on a positive feedback and delayed negative 
feedback architecture 12,13 (Figure 3.4A). In our oscillator network T3RNAP induces its own expression, which 
constitutes the positive feedback loop. The same polymerase also transcribes the supD and tetR genes to produce amber 
suppressor tRNA and tetR mRNA, which can only be translated when the suppressor tRNA concentration is sufficiently 
high. TetR then represses transcription of the T3RNAP gene, which eventually stops its own synthesis. Citrine and 
cerulean fluorescent proteins allowed us to simultaneously monitor expression from the two promoters in the system. 
Steady state conditions were necessary to produce oscillations, which we only observed in a narrow range of dilution 
rates (Figure 3.4B). The range of dilution rates that gave rise to oscillations increased with decreasing supD template 
concentration; supD was, however, necessary, as well as the other two components (Figure S3.3). Oscillation period 
increased linearly in a range of 4-16h as a function of residence time (Figure S3.4). These residence times correspond 
to cellular doubling times between 20 and 58min. A similar dependence of period on dilution rate has been found for 
bacterial growth rates 80. Apart from oscillations or damped oscillations two other general behaviors were observed: at 
high residence times reporter concentrations peaked once and then went to a low stable steady state, and at low 
residence times or when supD template was absent they immediately approached a stable steady state (Figure 3.4C).  
 
 
Figure 3.4 Steady state ITT conditions allow implementation of a genetic oscillator. 
(A) The oscillator consists of three DNA templates: T3RNAP, supD amber suppressor tRNA, and TetR repressor; and 
reporters for the two promoters in the network: yellow fluorescent protein (Citrine) and cyan fluorescent protein 
(Cerulean). (B) Phase diagram of the oscillator at different supD DNA template concentrations and different dilution 
rates. Oscillations (diamond symbols) occurred over a narrow range of dilution rates, which also determined the period of 
oscillations (fill color). Two other general behaviors were observed: one fluorescence peak and then low fluorescence 
(cross) or the system immediately reached a stable steady state (circles). (C) Cerulean (blue) and citrine (yellow) 
example traces. 
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3.5 Discussion 
Biological in vitro oscillations were previously only achieved in biochemically simple reactions, such as 
oligonucleotide-based systems containing an active degradation mechanism 12,13. Our genetic oscillator shows that 
continuous reaction conditions allow complex dynamics to occur in cell-free protein synthesis reactions, and in a 
sustained fashion. We observed that oscillations occurred in a narrow range of physiological dilution rates, which is 
important information for the implementation of in vivo oscillators, where dilution rates cannot be tuned as easily.  
The examples of regulators we implemented in this study show that there appear to be no major limitations in the 
control mechanisms that can be implemented in vitro. Nonetheless, there are still many mechanisms to be tested 
including different transcriptional repressors, transcriptional activators such as LuxR or protein phosphorylation. It may 
moreover be possible to use systems that could not be implemented in vivo because of interference with vital processes 
in the host. In the course of characterizing different regulators with the goal of identifying suitable candidates to 
assemble a genetic oscillator we found that E. coli RNA polymerase promoters recognized by σ70 often exhibited very 
low transcription rates. A recent report suggests that circular DNA might be a better template than linear DNA to 
reproduce in vivo transcription rates from E. coli promoters 34. In order to achieve tight repression of a strong promoter, 
we included two TetR operator sites into the T3 promoter, which explains its higher repression efficiency than the T7tet 
promoter.  The TetR repressed version of the E. coli promoter featured two operator sites but the considerably lower 
activity in the unrepressed state made it less suitable for our oscillator design. The combination of transcriptional 
strength and tight repression are desirable features of promoters in many synthetic networks and often not trivial to 
engineer 2,77. To achieve tighter control of the tetR gene in our oscillator network than transcriptional control could 
provide we added stop codon suppression as a second regulatory level. 
The reactor-based approach presented here allows bottom-up synthetic biology experiments to be performed in a 
completely defined and controlled environment. It differs from earlier designs of reactors for continuous ITT reactions 
52,54 in that it is not based on a size-exclusion membrane for exchange of molecules. In our microfluidic reactor based 
approach all molecules, including RNA polymerase, translation machinery and DNA template, are constantly 
exchanged. While the exchange of enzymes involved in the reaction ensures that synthesis rates stay at a constant 
steady state even if they degrade over time, it could be interesting to immobilize the DNA templates in the reactor, or to 
organize specific protein products in a spatial manner 81. Although our DNA template concentrations were in the range 
of low copy number plasmid concentrations in E. coli, RNA and protein concentrations were higher than average 
cellular concentrations. Due to the relatively large size of our nano-reactors (two orders of magnitude larger than the 
giant bacterium Epulopiscium 82), stochastic processes may be difficult to study at the moment 83. It should however be 
feasible to scale down the 33nL reactors by 1-2 orders of magnitude with existing microfabrication approaches 84 and to 
use E. coil RNAP instead of a phage RNAP. Down-scaling reactor volume would also permit hundreds to possibly 
thousands of reactors to be integrated on a single device 85,86. Combined with high-throughput DNA synthesis methods 
87 this approach would allow the rapid characterization of many synthetic network variants. Due to the fact that ITT 
reactions only require linear DNA templates, which were exclusively used in this study, such an in vitro screen would 
require no laborious cloning steps. 
It will be exciting to determine whether any fundamental limits exist to the complexity of systems attainable in vitro. 
The examples of regulator mechanisms implemented here show that there appear to be no major limitations in the 
control mechanisms that can be used. We were able to implement a genetic oscillator in vitro similar in complexity to 
synthetic gene networks achieved in vivo a few years ago 2. Our nano-reactor may prove to be a viable system to study 
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processes that would interfere with vital processes in vivo or processes that occur in organisms that are un-culturable. 
Furthermore, the system could be used to boot-up and test the biochemical subsystems of a minimal artificial cell 
including DNA-replication 21, the translation machinery, or biosynthesis of precursors 20.  
3.6 Methods 
Preparation of DNA templates 
PCR for linear DNA templates was performed as previously described 76. Primer sequences are listed in Table S3.1. 
PCR templates were pKT127 for EGFP 70, pKT211 for Citrine 70, pBS10 for Cerulean (Yeast resource center), 
BBa_K346000 (Registry of Standard Biological parts) for T3 RNA polymerase, repressilator plasmid 2 for tetR, E. coli 
DH5α genomic DNA for rpoD. Short DNA templates for supD (Registry of Standard Biological parts 
Part:BBa_K228001) and taR12 77 were created by PCR using overlapping oligonucleotides. Regulatory sequences such 
as promoter, ribosomal binding site, terminator and ssrA tag were included in the oligonucleotide primers. To monitor 
mRNA concentration, the EGFP template contained a target site for binary probes in its 3’ untranslated region 76. To 
monitor DNA concentration, the DNA template contained two Cy5 labels introduced by the 3’ and 5’ final primers.  
Reaction setup 
We used the commercial PURExpress ITT kit (New England Biolabs) and added water to a volume of 80% of the final 
reaction volume. The remaining 20% of the reaction volume consisted of DNA template at 5x of its final concentration. 
ITT and DNA fractions were combined on the microfluidic chip. If necessary, the ITT mix was supplemented with 
binary probes 76 at a final concentration of 1µM, E. coli RNA polymerase core- or holoenzyme (Epicenter) at 35 and 
25ng/µl respectively or 100nM T3 RNAP polymerase (Fermentas). For a steady state ITT reaction, ITT mix and DNA 
were combined in the reactors on the microfluidic chip in a 5:1 ratio. Every 15 min, the reactor was imaged and a 
fraction of the reactor volume was replaced with fresh ITT mix and DNA at 5:1 ratio. Details on operation and 
characterization of the microfluidic chip can be found in the SI Appendix. Final concentrations of DNA templates in the 
genetic oscillator were 5nM T3tet-T3RNAP, 10nM T3-amber-tetR, and variable T3-supD concentration (between 0 and 
100nM). The reporter template DNAs for T3-Citrine and T3-Cerulean were at 2.5nM each. Concentrations of DNA 
templates for the experiment with transcriptional and post-transcriptional regulators are summarized in Table S3.2. 
Data acquisition and analysis 
We used an inverted microscope with an automated stage to image the eight reactors on the chip. Fluorescence was 
determined by imaging the reactor channel using a 20x magnification and fluorescence filters for GFP, Cy3-Cy5 FRET, 
Cy5, YFP and CFP. Background fluorescence of a position next to the channel was subtracted from channel 
fluorescence. Concentrations of mRNA and EGFP were calculated from calibrations of FRET and EGFP fluorescence 
using purified molecules 76. To determine mRNA concentrations we performed a blank reaction without DNA template 
in one of the reactors and subtracted FRET background fluorescence. Additionally, we normalized to average blank 
FRET fluorescence. To determine the period of sustained and damped oscillations of the genetic oscillator we measured 
the time between the first and the second fluorescence maximum for both CFP and YFP fluorescence and used the 
average. Data was analyzed using IgorPro and MATLAB software. 
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3.7 Fabrication, design and operation of the nano-reactor device 
Design and fabrication 
We designed a two-layer microfluidic chip to perform ITT reactions at steady state (Figure 3.5). The design of the 
microfluidic chip is similar to previous devices 73-75. One chip contains eight reaction rings to simultaneously run eight 
independent experiments. Different reagents can be connected to nine fluid inlets, which can be addressed by a 
multiplexer. Fluid bypasses allow rapid flushing of channels leading to the reaction rings. The inlet of each reaction ring 
can be opened and closed independently from the others. A peristaltic pump in front of the rings is used to meter 
reagents into the reaction rings. A second peristaltic pump is used to mix the contents inside the rings. The design 
allowed us to use, different dilution rates or different template DNAs in each of the nanoreactors. Each nanoreactor had 
a volume of 33nL. 
Molds for the control and the flow layer were fabricated on separate wafers by standard photolithography techniques 
and patterned with photoresist to produce channels with the heights stated in Figure 3.5. To ensure a homogenous film 
of photoresist on the mold for the flow layer, we applied the thinner AZ9260 first, and developed, before we spin-
coated the thicker SU8 layer. The microfluidic chips were fabricated from PDMS by standard multilayer soft 
lithography88. The control layer was located at the bottom of the chip and plasma bonded to a glass slide. 
 
 
 
Figure 3.5 Design of the microfluidic chip. 
(A) Design of the full microfluidic device. (B) Close-up of a reaction ring. The control layer is shown in red and the flow 
layer in two shades of blue. The width of a flow channel or a control valve is 100µm. (1) Reagent inlets, (2) multiplexer, 
(3) reaction ring and imaging position, (4) peristaltic pump for mixing of reagents in the reaction ring, (5) peristaltic pump 
to add reagents into the reaction ring, (6) bypass channel. (C) Channel heights and photoresists used. 
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Operation of the nano-reactor device 
Pressure of microfluidic flow and control was regulated by a custom pneumatic setup. Control lines were set to 40psi, 
except the three lines, which controlled the peristaltic mixing pump, which were set to 20 psi using a separate pressure 
gauge and were additionally connected to a vacuum pump. Microfluidic valves were actuated by computer-controlled 
solenoid valves operated by a custom written LabView program. Depending on the experiment, flow pressure was 
regulated between 5 and 9psi to achieve additions between 0.4 and 1% of the ring volume per pump cycle. Usually, the 
flow pressure was set to the value, where one pump cycle of the peristaltic input pump corresponded to 0.8% of the 
reactor volume. 
The device was placed on an automated microscope in an opaque, temperature controlled incubation chamber, which 
allowed fluorescent imaging and a constant reaction temperature set to 37°C. One critical feature enabling long-term 
reaction conditions, was cooling of the ITT mixture before it enters the microfluidic chip, which was accomplished with 
a combination of a peltier element and water cooled heat sink (Figure 3.6). The volume of ITT mixture for the entire 
experiment was aspirated into a FEP (fluorinated ethylene propylene) tube, for storage on the peltier element. This tube 
was then connected to the microfluidic chip via a PEEK (polyether ether ketone) tube (Vici) with a thin inner diameter 
(180µm) to reduce the volume of un-cooled ITT reagent. For all other reagents we used tygon tubing without cooling.  
 
 
 
Figure 3.6 Cooling of the ITT mix. 
Schematic of the custom-built cooling system for the ITT mix. The FEP tube holding the ITT mix for the experiment is 
held on top of a peltier element (Laird Technologies), it is connected to the microfluidic chip via a PEEK tube with a thin 
inner diameter (180µm). The heat sink for the peltier element is a copper plate cooled by a CPU cooler (EK waterblocks) 
connected to a water pump regulated to 8°C (Solid State cooling systems).  In order to prevent condensation and ice 
formation on the edge of the peltier element facing the microfluidic chip, we placed a fan on the opposite site of the 
device. This temperature control system kept the ITT mix in the storage tube at approximately 6°C while the on-chip 
reaction temperature was 37°C, the temperature in the incubation chamber enclosing the setup. 
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Characterization of the nano-reactor device 
The volume added into the reaction rings per pump cycle of the peristaltic input pump was consistent across the eight 
reactors on the chip and increased linearly with the number of pump cycles (Figure 3.7A). Before each experiment, the 
dilution rate was determined by measuring the washout rate of EGFP fluorescence (Figure 3.7B). 
We measured the speed at which reagents inside the reactions rings were mixed by adding a plug of fluorescent EGFP 
solution into the rings. One position of the channel was imaged while the peristaltic pump started moving the 
fluorescent plug in a circle, which leads to mixing (Figure 3.8). Within less than 2 min mixing was completed. 
 
 
 
Figure 3.7 Characterization of the peristaltic input pump. 
(A) Volume added into the reactors depends linearly on the number of pump cycles. Shown are the results from eight 
reactors of the same device. (B) Washout from the reactor at different dilution rates. Shown are the results of eight 
reactors from one device, with two repeats of each dilution rate (markers), and the prediction for a washout of 16, 24, 32 
and 40% of reactor volume per dilution step (dashed lines). In both panels one pump cycle displaced 0.8% of the reactor 
volume. 
 
 
 
 
Figure 3.8 Mixing of reagents in the reaction rings. 
To reaction rings filled with 2% BSA in PBS a plug of 7% of the reactor volume of 100µg/ml EGFP was added with the 
peristaltic input pump. The reactor channel was imaged while the peristaltic mixing pump moved the EGFP plug in a 
circle, causing the solutions to mix. 
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Experimental procedure 
Priming and calibration 
At the beginning of each experiment the device was primed with a solution of 2% BSA in PBS. Then, the dilution rates 
were calibrated as shown in Figure 3.7B. This ensured correct functioning of the device before start of the experiment 
and to adjust the dilution rates to the desired value. 
Steady state ITT reaction 
Operation of the microfluidic chip and imaging during steady state ITT reactions was fully automated with a custom 
written LabView program. The sequence of operations was as follows: 
Step Operation 
0 Initial fill: 
- flush reactors with ITT mixture 
- meter 20% reactor volume of template DNA into the reactors 
- mix 
 Repeat the following steps every 15min: 
1 Image each reactor 
2 Flush the bypass channels with buffer 
3 Addition of fresh ITT mix: 
- flush the bypasses channels with ITT mixture 
- add 4*n pump cycles of ITT mixture into the reactors 
- flush the bypass channels with buffer 
4 Addition of DNA: 
- flush the bypasses channels with DNA solution 
- add n pump cycles of DNA into the reactors 
- flush the bypass channels with buffer 
5 Mix 
6 Repeat from step 1 
 
Flushing of the bypass channels with costly reagents like ITT mixture and DNA solutions was done with the peristaltic 
input pump in order to reduce reagent consumption. For a complete experiment of 30h, only 6.25µl of ITT mixture 
were required per reactor. The buffer used for flushing was 5mM Tris-HCl pH8.5. The peristaltic mixing pump was 
actuated with a frequency of 8.3Hz. The input pump was actuated with a frequency of 1.7Hz for flushing the bypass 
channel, and with a frequency of 0.3Hz to add reagents into the reactions rings. 
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3.8 Model of an ITT reaction in the nano-reactor device 
Model of a batch ITT reaction 
We describe the ITT reaction in batch with a set of six differential equations 
DNA, d: 
(1) d '(t) = 0  
mRNA, m: 
(2) m '(t) = TX(d) ! actTX (t) " degm !m(t)  
dark (immature) EGFP, pd: 
(3) pd '(t) = TL(m) ! actTL (t) " mat ! pd (t)  
fluorescent (mature) EGFP, pf: 
(4) p f '(t) = mat ! pd (t)  
Relative transcriptional activity, actTX: 
(5) actTX '(t) = ! degTX " actTX (t)   
Relative translational activity, actTL: 
(6) actTL '(t) = ! degTL " actTL (t)  
We determined each parameter of this model in separate experiments. TX is the initial transcription rate that depends on 
DNA template concentration. TL is the initial translation rate that depends on mRNA concentration. We assume an 
unspecific decrease of those activities as a function of time and use actTX and actTL as the relative activities left at a 
given time. RNA, transcriptional activity and translational activity degrade/decrease with rates degm, degTX, degTL 
respectively. Dark EGFP matures to fluorescent EGFP with the rate mat. We did not observe any degradation of 
fluorescent EGFP. 
 
Degradation of mRNA 
The rate of mRNA degradation was determined as in76 by monitoring the decrease of a known concentration of purified 
mRNA,m0, in an on-chip batch reaction (Figure 3.9). The decreasing RNA concentration was fit to the solution of 
equation (2), with TX=0: 
(7) m(t) = m0 ! e
"degm!t  
In different experiments and at different initial RNA concentrations we measured degradation rates between 0.003 and 
0.008 min-1. For the model, we used a RNA degradation rate degm of 0.003 min-1. 
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Figure 3.9 On-chip measurement of mRNA degradation rate. 
Different concentrations of purified mRNA were added to an ITT reaction on chip. Concentration of mRNA was monitored 
over time and fit to equation (7) (dashed lines). 
 
 
Initial rate of transcription  
We determined the initial transcription rate as a function of DNA in an on-chip batch reaction as in 76. The initial 
change in mRNA concentration can be described by equation (8) and we fit RNA concentration during the initial phase 
of the reaction to the solution, equation (9) (Figure 3.10A).  
(8) m '(t) = TX(d) ! degm "m(t)  
(9) m(t) = TX(d)
degm
! (1" e"degm!t )  
Transcription can be described by Michaelis-Menten kinetics: 
(10) TX(d) = TXmax ! d
KTX + d
 
The maximal initial transcription rate, TXmax, was 11.5 nM/min and the DNA concentration for half maximal activity, 
KTX, was 5.5nM (Figure 3.10B). 
 
 
Figure 3.10 On-chip measurement of initial transcription rate. 
(A) RNA synthesis from different DNA template concentrations was monitored and the concentration during the initial 50 
min of the reaction was fit to equation (9) using a fixed mRNA degradation rate, degm, of 0.003 min-1 (dashed lines) to 
determine TX(d). (B) Initial transcription rates as determined in (A) and fit to Michaelis-Menten kinetics (equation 10). 
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Relative transcriptional activity over time 
The relative transcriptional activity of an on-chip batch reaction over time was determined for RNA synthesis from 
different template DNA concentrations as in76 using Euler’s method (Figure 3.11):  
(11) m(t + !t) = m(t) + (TX(d) " actTX (t) # degm "m(t)) " !t  
(12) actTX (t) =
m(t + !t) " m(t) + degm #m(t) # !t
TX(d) # !t
. 
We approximated the mode of transcriptional activity decrease by exponential decay (see equation 5). The rate of the 
decrease in relative transcriptional activity, degTX, was on average 0.005 min-1. 
 
 
Figure 3.11 On-chip relative transcriptional activity over time. 
The relative transcriptional activity with respect to its initial value was calculated for RNA synthesis from different DNA 
template concentrations using equation (12) (dots) and the previously determined rates. These traces were smoothed for 
visualization (lines) and fit to an exponential decay function to determine the rate of decrease (dashed lines). 
 
 
Maturation of EGFP 
To determine the maturation rate of EGFP in our experimental conditions an ITT reaction producing EGFP was stopped 
by adding RNase, which immediately stops translation. Any increase of EGFP after this addition was therefore due to 
maturation of dark EGFP to fluorescent EGFP. This simplifies equation (3) to 
(13) pd '(t) = !mat " pd (t)  
With this, the solution of equation (4) is: 
(14) p f (t) = p0 + !p " (1# e
#mat"t )  
p0 is the concentration of fluorescent EGFP when translation is stopped and Δp is the increase in its concentration when 
all dark EGFP is completely converted to fluorescent EGFP. EGFP maturation rate was determined to be 0.1 min-1 
(Figure 3.12). 
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Figure 3.12 On-chip maturation of EGFP. 
After 25 min of an on-chip ITT reaction from a DNA template, translation was stopped by adding 0.6µM RNase. 
Concentration of fluorescent EGFP after RNase addition (lines) was fit to equation (14) to determine the maturation rate. 
 
Initial rate of translation 
We measured EGFP synthesis from different concentrations of purified mRNA. In the initial phase of this reaction, not 
taking into account a decrease of translational activity over time, this simplifies equations (2) and (3) to 
(15) m '(t) = ! degm "m(t)  
(16) pd '(t) = TL(m) ! mat " pd (t)  
With TL(m) =!TL !m(t)  and pf(0)=pd(0)=0, the solution of equations (15), (16) and (4): 
(17) p f (t) =
!TL !m0
degm ! (degm" mat)
! (mat ! (e"degm!t "1) + degm ! (1" e"mat!t )) . 
Concentration of fluorescent EGFP of the initial phase of the reaction was fit to equation (17) to determine αTL (Figure 
3.13A). Translation follows Michaelis-Menten kinetics: 
(18) TL(m) = TLmax !m
KTL + m
. 
KTL, the mRNA concentration at half-maximal translation rate, was determined from multiple benchtop experiments to 
be 150.2 nM. This KTL was used to determine the average TLmax of two independent on-chip reactions. The TLmax on-
chip was lower than in a benchtop reaction and also more variable (Figure 3.13B). For the model we used an average 
value of 76.4 nM/min. 
 
Figure 3.13 On-chip measurement of initial translation rate. 
(A) On-chip EGFP synthesis from different mRNA template concentrations was monitored and the concentration during 
the initial 20 min of the reaction was fit to equation (17) using the known initial mRNA concentration m0 and the 
previously determined rates, degm and mat (dashed lines) to determine αTL. (B) Initial transcription rates, TL, in a 
benchtop reaction (red crosses) and in two independent on-chip experiments (black circles) as determined in (A) were fit 
to Michaelis-Menten kinetics (equation 18) (dashed lines). 
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Translational activity over time 
Translational activity over time was determined by Euler’s method. Equations (15), (3) and (4) can be written as 
(19) m(t + !t) = m(t) " degm #m(t) # !t  
(20) pd (t + !t) = pd (t) + !t " (actTL (t) "TL(m) # mat " pd (t))  
(21) p f (t + !t) = p f (t) + !t "mat " pd (t) . 
From the known initial mRNA concentration, we calculated the mRNA concentration at each later time point. We had 
measured the concentration of fluorescent EGFP, pf. Using smoothed pf values we determined the concentration of dark 
EGFP, from equation (21): 
(22) pd (t) =
p f (t + !t) " p f (t)
!t #mat
. 
This allowed us to calculate the relative translational activity, actTL at each time point, which is the fraction of the initial 
activity left. 
(23) actTL (t) =
pd (t + !t) " pd (t) + mat # pd (t) # !t
!t #TL(m)
. 
Within one experiment the rate of decrease of translational activity was very consistent and did not depend on the 
mRNA concentration used (Figure 3.14). The average rate of activity decrease determined from two independent on-
chip experiments was 0.017min-1. 
 
Figure 3.14 Relative translational activity over time. 
In two independent on-chip experiments (A and B) EGFP was synthesized from different initial concentrations of purified 
mRNA. The relative translational activity with respect to its initial value was calculated using equations (19), (22), (23) 
and smoothed EGFPf measurement traces. The relative activities over time were then fit to an exponential decay 
function to determine the rate of decrease (dashed lines). 
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Summary of rates 
The rates we measured here for a batch reaction on chip compared well with rates that were previously determined for 
the same ITT reaction mixture for bench-top reaction with larger volumes11,76. The following table summarizes all the 
rates we determined in the sections above that describe a batch reaction on chip, and that we used in our model: 
Rate Value 
RNA degradation rate, 
degm 
0.003 min-1 
Initial transcription rate,  
TX(d) 
TX(d)
11.5 nM
min
! d
5.5nM + d
 
Rate of relative transcriptional activity decrease, 
degTX 
0.005 min-1 
EGFP maturation rate, mat 0.1 min-1 
Initial translation rate,  
TL(m) 
TL(m)
76.4 nM
min
!m
150.2nM + m
 
Rate of relative translational activity decrease, 
degTX 
0.017 min-1 
 
Model of a continuous reaction with dilutions 
To describe the continuous reaction in the microfluidic reactor we modeled the processes of the batch ITT reaction in 
discrete time intervals, Δt, of one minute. Every 15min a dilution fraction, dil (between 0.16 and 0.4, depending on the 
dilution conditions), was removed from the concentrations of the modeled molecules and the transcription and 
translation activities, which constitutes the washout. Also every 15min, full transcription and translation activities and 
DNA concentration, all scaled by fraction dil, were added: 
  Every 15 min 
DNA d(t + !t ) = d(t )  !dil " d(t ) + c " dil " d(t )  
mRNA m(t + !t ) = m(t ) + !t " (TX(d) " actTX (t ) # degm "m(t ))  !dil "m(t )  
EGFPd pd (t + !t ) = pd (t )+ !t " (TL(m) " actTL (t ) # mat " pd (t ))  !dil " pd (t )  
EGFPf p f (t + !t ) = p f (t ) + !t "mat " pd (t )  !dil " p f (t )  
Rel. TX act actTX (t + !t ) = actTX (t ) " !t # degTX # actTX (t )  !dil " actTX (t ) + dil  
Rel. TL act actTL (t + !t ) = actTL (t ) " !t # degTL # actTL (t )  !dil " actTL (t ) + dil  
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Concentration, c, of DNA is usually equal to the initial DNA concentration d(0), in which case DNA concentration is 
constant. In special cases c can change transiently during the experiment, which leads to a new steady state DNA 
concentration, c. 
Initial conditions 
d(0) varied from experiment to experiment. In continuous ITT reactions m(0)=pd(0)=pf(0)=0 and actTX(0)=actTL(0)=1. 
Prediction of transcriptional and translational activities at different dilution rates 
The predicted relative transcriptional and translational steady state activities depended on the dilution rate. The higher 
the dilution rate, the higher was the steady state activity. Figure 3.15 shows the predicted relative transcriptional and 
translational activities for the experiments of Figure 3.2. 
 
Figure 3.15 Predicted relative transcriptional and translational activities at different reaction conditions. 
(A) Long-term steady state ITT at different dilution rates. The predicted relative transcriptional and translational activities 
shown here correspond to the experiment and predictions in Figure 3.2B. (B) Transient switch to batch conditions. No 
dilutions occurred in the shaded time span. The predicted relative transcriptional and translational activities shown here 
correspond to the experiment and predictions in Figure 3.2C. Relative activities were modeled with discrete dilution steps 
every 15min, which cause the teeth-like fluctuations. 
 
Model of the repressilator in batch and continuous reaction 
The repressilator consists of three transcriptional repressors, which each inhibit the expression of the preceding gene in 
the network 2. We modeled the repressilator as a symmetric system, where all repressors are identical except for their 
DNA-binding specifities, using the following differential equations for mRNA and protein concentration of the three 
repressors, R1-3 (i = R2, R3, R1 and j = R1, R2, R3): 
mi '(t) = actTX (t) !
TX !Kmn
Kmn + p j
n " degm !mi (t) " dil !mi (t) , 
pi '(t) = actTL (t) !
mi (t)
mtotal (t)
!TL(mtotal (t)) " degp !mi (t) " dil !mi (t) . 
We set the transcription rate at the unrepressed state, TX, of each promoter to 3nM/min, the Michaelis constant, Km, to 
40nM and the Hill coefficient, n, to 2. The translation rate, TL, was calculated from equation 18. To take into account 
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saturation of the translation machinery at high mRNA concentration we determined the translation rate for total mRNA 
concentration, mtotal, and scaled by the fraction of mRNA concentration of the repressor modeled in that case. 
Transcription and translation activities were modeled as above, using the following differential equations: 
actTX '(t) = ! degTX " actTX (t) ! dil " actTX (t) + dil , 
actTL '(t) = ! degTL " actTL (t) ! dil " actTL (t) + dil . 
We compared behavior of the oscillator under batch and continuous reaction conditions. Additionally we modeled an 
“improved” batch reaction, where mRNA degradation and protein degradation rates are increased to in vivo levels of E. 
coli50,89, and where the rates of activity decrease of transcription and translation were a 10th of the rates we measured. 
These improvements seem experimentally feasible, if mRNA and protein degradation mechanisms 50 and feeding of the 
ITT reaction by diffusion of small molecules 45,55 were combined. The values of the following parameters were varied 
as follows in the three different reaction conditions:  
 Reaction conditions 
Parameter Batch Improved batch Continuous 
Dilution rate, dil 0 0 1.54h-1 
mRNA degradation, degm 0.003min-1 0.053min-1 0.003min
-1 
Protein degradation, degp 0 0.017min-1 0 
Decrease of transcriptional 
activity, degTX 
0.005min-1 0.0005min-1 0.005min-1 
Decrease of translational 
activity, degTL 
0.017min-1 0.0017min-1 0.017min-1 
Initial conditions were 1nM for all mRNA species, 0 for protein concentrations of R1 and R2 and 100nM of protein R3. 
Initial relative transcriptional and translational activities were 1. We show concentration of repressor protein R3 in 
Figure 3.1E. 
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3.9 Supplementary Information 
 
Table S1. Oligonucleotide primers used in the study. 
 
Use and primer name Sequence 
Gene specific primers 
Color annotations:   Ribosomal binding site   Amber stop codon   ssrA tag 
EGFP/Citrine-fwd CCTCTAGAAATAATTTTGTTTAACTTAAGAAGGAGGAAAAAAAAATGTCTA
AAGGTGAAGAATTATTCAC 
amber-EGFP-fwd CCTCTAGAAATAATTTTGTTTAACTTAAGAAGGAGGAAAAAAAAATGTAGA
AAGGTGAAGAATTATTCACTG 
EGFP/Citrine-rev GTAGCAGCCTGAGTCGTTATTATTTGTACAATTCATCCATACCATGG 
EGFP-ssrA-rev GTAGCAGCCTGAGTCGTTATTAAGCAGCCAGAGCGTAGTTTTCGTCGTTAG
CAGCTTTGTACAATTCATCCATACCATGG 
T3RNAP-fwd CCTCTAGAAATAATTTTGTTTAACTTAAGAAGGAGGAAAAAAAA 
ATGAACATCATCGAAAACATCG 
T3RNAP-rev GTAGCAGCCTGAGTCGTTA TTATGCAAAGGCAAAGTCAGAC 
rpoD-fwd CCTCTAGAAATAATTTTGTTTAACTTAAGAAGGAGGAAAAAAAA 
ATGGAGCAAAACCCGCAG 
rpoD-rev GTAGCAGCCTGAGTCGTTATTATTAATCGTCCAGGAAGCTACGC 
tetR-fwd CCTCTAGAAATAATTTTGTTTAACTTAAGAAGGAGGAAAAAAAAATGTCCA
GATTAGATAAAAGTAAAG 
amber-tetR-fwd CCTCTAGAAATAATTTTGTTTAACTTAAGAAGGAGGAAAAAAAAATGTAGA
GATTAGATAAAAGTAAAG 
tetR-rev GTAGCAGCCTGAGTCGTTATTAAGACCCACTTTCACATTTAAG 
clpX-fwd CCTCTAGAAATAATTTTGTTTAACTTAAGAAGGAGGAAAAAAAAATGACA
GATAAACGCAAAGATG 
clpX-rev GTAGCAGCCTGAGTCGTTATTA TTCACCAGATGCCTGTTG 
clpP-fwd CCTCTAGAAATAATTTTGTTTAACTTAAGAAGGAGGAAAAAAAAATGTCAT
ACAGCGGCGAAC 
clpP-rev GTAGCAGCCTGAGTCGTTATTAATTACGATGGGTCAGAATCGAATC 
Cerulean-fwd CCTCTAGAAATAATTTTGTTTAACTTAAGAAGGAGGAAAAAAAAATGAGTA
AAGGAGAAGAACTTTTC 
Cerulean-rev GTAGCAGCCTGAGTCGTTATTATTTGTATAGTTCATCCATGCC 
5’ extension primers: 
Color annotations:   Promoter   tet operator 
5’ext-T7_no-tgt GATCTTAAGGCTAGAGTACTAATACGACTCACTATAGGGAGACCACAACG
GTTTCCCTCTAGAAATAATTTTGTTTAAC 
5’ext-T7tet GATCTTAAGGCTAGAGTACTAATACGACTCACTATAGGGAGATCTCCCTAT
CAGTGATAGACCTCTAGAAATAATTTTGTTTAAC 
5’ext-T3 GATCTTAAGGCTAGAGTACAATTAACACTCACTAAAGGGAGACCTCTAGAA
ATAATTTTGTTTAAC 
5’ext-T3tet GATCTTAAGGCTAGAGTACTCCCTATCAGTGATAGAATTAACACTCACTAA
AGGGAGATCCCTATCAGTGATAGACCTCTAGAAATAATTTTGTTTAAC 
5’ext-E.c.lac GATCTTAAGGCTAGAGTACAATTGTGAGCGGATAACAATTGACATTGTGAG
CGGATAACAATATAATATGCGCATCCTCTAGAAATAATTTTGTTTAAC 
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5’ext-E.c.tet GATCTTAAGGCTAGAGTACTCCCTATCAGTGATAGAGATTGACATCCCTAT
CAGTGATAGATATAATATGCGCATCCTCTAGAAATAATTTTGTTTAAC 
3’ extension primers: 
Color annotations:   Terminator 
3’ext_no-tgt CAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGGGTTATGCTAGTTT
TTTTTTTTTTTTTTTTTTTTTTTTTTTGTAGCAGCCTGAGTCG 
3’ext_3’tgt-3 CAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGGGTTATGCTAGTTT
TTTTTTTTTTTTTTTTTTTTTTTTTTTGATAGAGTCCTTCCACGATACCAATGG
GCTCAGTTTTTTGTTTTTTGGGTTTTGGTTTTGTTTTCCAGTACACAGGCGTA
GCAGCCTGAGTCG 
Final amplification primers: 
5’final GATCTTAAGGCTAGAGTAC or /Cy5/GATCTTAAGGCTAGAGTAC 
3’final CAAAAAACCCCTCAAGAC or /Cy5/CAAAAAACCCCTCAAGAC  
Specialized primer sets: 
Color annotations:   Promoter   Ribosomal binding site 
supD:  
T7-supD-fwd GATCTTAAGGCTAGAGTACTAATACGACTCACTATAGGAGAGATGCCGGA
GCGGCTGAACGGACCGGTCTC 
T3-supD-fwd GATCTTAAGGCTAGAGTACAATTAACACTCACTAAAGGAGAGATGCCGGA
GCGGCTGAACGGACCGGTCTC 
supD-rev TGGCGGAGAGAGGGGGATTTGAACCCCCGGTAGAGTTGCCCCTACTCCGGT
TTTAGAGACCGGTCCGTTCAGCCG 
T7-cr-EGFP:  
cr-EGFP-fwd 
(gene specific primer) 
GGGTATTAAAGAGGAGAAAGGTACCATGTCTAAAGGTGAAGAATTATTCA
C 
5’ext-crR12-5’ 
(upstream part of 5’ext) 
GATCTTAAGGCTAGAGTACTAATACGACTCACTATAGGGAGAATTCTACCA
TTCACC 
5’ext-crR12-3’ 
(downstream part of 
5’ext) 
GGTACCTTTCTCCTCTTTAATACCCAAATCCAAGAGGTGAATGGTAGAATT
CTCCCT 
T7-taR12:  
T7-taR12-fwd GATCTTAAGGCTAGAGTACTAATACGACTCACTATAGGACCCAAATCCAGG
AGGTGATTGGTAG 
taR12-rev TCTAGAGATATATGGTAGTAGTAAGTTAATTTTCATTAACCACCACTACCA
ATCACCTCCTGGATTTG 
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Table S3.2. DNA template concentrations for experiments in Figure 3.3. All reporter DNA templates contained a target 
site for binary probes to determine EGFP mRNA concentrations. 
 
Experiment Regulator DNA Reporter DNA 
Transcriptional activation (Figure 3A) 
by T3 RNA polymerase 
 1nM T7-T3RNAP 5nM T3-EGFP 
control 1nM T7-rpoD 5nM T3-EGFP 
by sigma factor 70 (rpoD) 
 1nM T7-rpoD 10nM E.c.tet-EGFP 
control 1nM T7-T3RNAP 10nM E.c.tet-EGFP 
Transcriptional repression by TetR (Figure 3B) 
T7 RNA polymerase promoter 
 1nM T7-tetR 4nM T7tet-EGFP 
control 1nM T7-tetR 4nM T7-EGFP 
T3 RNA polymerase promoter 
 1nM T7-tetR 4nM T3tet-EGFP 
control 1nM T7-tetR 4nM T3-EGFP 
E. coli RNA polymerase holoenzyme 
 1nM T7-tetR 4nM E.c.tet-EGFP 
control 1nM T7-tetR 4nM E.c.lac-EGFP 
Translational activation (Figure 3C) 
by amber suppressor tRNA (supD) 
 20nM T7-supD 10nM T7-amber-EGFP 
control 20nM T7-taR12 10nM T7-amber-EGFP 
by trans-activator RNA (taR12) 
 20nM T7-taR12 10nM T7-cr-EGFP 
control 20nM T7-supD 10nM T7-cr-EGFP 
Protein degradation by ClpXP (Figure 3D) 
of EGFP with degradation tag (ssrA) 
 2nM T7-clpX + 
2nM T7-clpP 
4nM T7-EGFP-ssrA 
control 2nM T7-clpX 4nM T7-EGFP-ssrA 
control 2nM T7-clpP 4nM T7-EGFP-ssrA 
of EGFP without degradation tag 
control 2nM T7-clpX + 
2nM T7-clpP 
4nM T7-EGFP 
control 2nM T7-clpX 4nM T7-EGFP 
control 2nM T7-clpP 4nM T7-EGFP 
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Figure S3.1. DNA concentration during steady state ITT. DNA concentration during the steady state reaction at 
different dilution rates shown in Fig. 2B was monitored via Cy5 fluorescence of the labeled DNA template. 
 
 
 
 
Figure S3.2. Quantitative effects of post-transcriptional regulators. (A) Expected EGFP concentration calculated 
from measured mRNA concentrations for translational activation (Fig. 3C). (B) Ratio of observed to expected EGFP 
concentration, translation efficiency. (C) Expected EGFP concentration calculated from measured mRNA 
concentrations for protein degradation (Fig. 3D). (D) Ratio of observed to expected EGFP concentration to quantify 
the influence of protein degradation. 
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Figure S3.3. Influence of the three oscillator genes. (A) Network design of the genetic oscillator. Concentrations of 
the oscillator DNA templates were 5nM T3tet-T3RNAP, 60nM T3-supD, 10nM T3-amber-tetR. We used the T3-EGFP 
reporter (5nM) with probe target site to determine mRNA concentration of the reporter during the reaction. (B) One 
network component was omitted at a time to determine if they were necessary to produce oscillations. Reactions 
were performed with a residence time of 49 min. 
 
 
 
 
Figure S3.4. Oscillation period versus residence time. Oscillation periods from experiments with different T3-supD 
DNA concentration (Figure 4) were plotted against residence time. 
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Chapter 4 A cell-free framework for biological systems 
engineering 
Niederholtmeyer H*1, Sun ZZ*2, Hori Y2, Yeung E2, Verpoorte A1, Murray RM2, and Maerkl SJ1. (2015) bioRxiv, 
018317. 
* HN and ZZS contributed equally to this work 
1 Institute of Bioengineering, École Polytechnique Fédérale de Lausanne, Switzerland. 2 Division of Biology and 
Biological Engineering, California Institute of Technology, Pasadena, United States of America 
 
4.1 Summary 
While complex dynamic biological networks control gene expression and metabolism in all living organisms, 
engineering comparable synthetic networks remains challenging 3,5. Conducting extensive, quantitative and rapid 
characterization during the design and implementation process of synthetic networks is currently severely limited due to 
cumbersome molecular cloning and the difficulties associated with measuring parts, components and systems in cellular 
hosts. Engineering gene networks in a cell-free environment promises to be an efficient and effective approach to 
rapidly develop novel biological systems and understand their operating regimes3,5,90-92. However, it remains 
questionable whether complex synthetic networks behave similarly in cells and a cell-free environment, which is critical 
for in vitro approaches to be of significance to biological engineering. Here we show that synthetic dynamic networks 
can be readily implemented, characterized, and engineered in a cell-free framework and consequently transferred to 
cellular hosts. We implemented and characterized the “repressilator”2, a three-node negative feedback oscillator in vitro. 
We then used our cell-free framework to engineer novel three-node, four-node, and five-node negative feedback 
architectures going from the characterization of circuit components to the rapid analysis of complete networks. We 
validated our cell-free approach by transferring these novel three-node and five-node oscillators to Escherichia coli, 
resulting in robust and synchronized oscillations reflecting the in vitro observation. We demonstrate that comprehensive 
circuit engineering can be performed in a cell-free system and that the in vitro results have direct applicability in vivo. 
Cell-free synthetic biology thus has the potential to drastically speed up design-build-test cycles in biological 
engineering and enable the quantitative characterization of synthetic and natural networks. 
4.2 Results and discussion 
A central tenet of engineering involves characterizing and verifying prototypes by conducting rapid design-build-test 
cycles in a simplified environment. Electronic circuits are tested on a breadboard to verify circuit design and aircraft 
prototypes are tested in a wind tunnel to characterize their aerodynamics. A simplified environment does not exist for 
engineering biological systems, nor is accurate software based design possible, requiring design-build-test cycles to be 
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conducted in vivo5. To fill the gap between theoretical design and laborious in vivo implementation for biological 
systems we devised a cell-free framework consisting of E. coli lysate (“TX-TL”)92,93 and a microfluidic device capable 
of emulating cellular growth and division90 (Figure 4.1). Almost all prototyping can be done on linear DNA, which 
requires less than 8 hours to assemble and test. The cell-free framework provides a simplified and controlled 
environment that allows us to drastically reduce the design-build-test cycle33.  
 
 
Figure 4.1 Cell-free framework allows for rapid and extensive characterization of biological systems. 
Schematic representation of the design-build-test cycle using the cell-free framework. A design is first modeled to obtain 
intuition about the architecture. Parts are then assembled on linear DNA without cloning, and tested in vitro. With 
functional parts, circuit variants can then be tested and working circuits can be extensively characterized. Final circuits 
are cloned onto plasmids and implemented in vivo. Center shows the microfluidics device used. Input is a circuit 
encoded by linear or plasmid DNA and TX-TL in vitro reagent, which is then translated and transcribed into protein. For a 
specific example of the cell-free framework applied to engineering a 5-node oscillator network see Fig. S4.3. 
 
We first asked whether our cell-free framework could be used to run and characterize an existing synthetic in vivo 
circuit and chose to test the repressilator2 as a model circuit. We successfully implemented the original repressilator 
network in our cell-free framework and observed long-term sustained oscillations with periods matching the in vivo 
study  (Figure 4.2). We compared the original repressilator to a modified version containing a point mutation in one of 
the CI repressor binding sites in the promoter regulating LacI (Figure 4.2a). This mutation increases the repressor 
concentration necessary for half-maximal repression (KM), and reduces cooperativity94. At long dilution times (td) both 
circuits oscillated, but with shifted absolute reporter protein concentrations (Figure 4.2b). At decreasing dilution times 
amplitudes decreased and periods became faster with a linear dependence on td. Faster dilution times, however, did not 
support oscillations for the modified network (Figure 4.2b-c). Experimentally, the range of dilution times supporting 
oscillations can serve as a measure for robust oscillator function, which generally diminishes with decreasing synthesis 
rates or when binding of one repressor to its promoter is weakened as in the OR2* mutant (Fig. S4.1). To give another 
example for an experimental characterization that would be challenging to perform in a cellular environment we 
analyzed the repressilator network in phase space showing limit cycle oscillations and invariance to initial conditions 
(Figure 4.2d).  
7. Implement: 
in vivo
2. Model: 
in silico 
4a. Test parts: in vitro
5 hours
1. Design: 
circuit concept
5. Characterize: working circuits
3. Build: parts on linear DNA
3 hours
6. Clone and Verify
4b. Test circuits: 
multiple variants(input)TX-TL + DNA 
(output)
Protein 
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Figure 4.2 Cell-free repressilator characterization. 
a, Application of the cell-free framework to characterize the original repressilator2 and a modified version with a point 
mutation in the CI promoter (OR2*) located in one of the binding sites of the CI repressor. b, Expression from the three 
promoters of the repressilator and the OR2* version at different dilution times. c, Oscillation periods of the repressilator as 
a function of dilution time. In the OR2* version sustained oscillations were supported in a narrower range of dilution times 
as compared to the original repressilator network. d, Phase portrait of repressilator oscillations starting from different 
initial TetR and CI repressor concentrations. 
 
The cell-free framework also allows rapid characterization of individual network components. We measured the 
transfer functions of repressor-promoter pairs in the repressilator network (Figure 4.3, Fig. S4.2a,b, Table S4.1) and 
found that the network is symmetric in terms of transfer functions. In the CI promoter OR2* mutant we observed the 
expected shift in KM and decreased steepness of the transfer function. We also characterized TetR repressor homologs 
as building blocks for novel negative feedback circuits (Figure 4.3a) and with the exception of QacR observed similar 
transfer functions as observed in vivo95 (Fig S4.2c).  
Using three new repressors, BetI, PhlF and SrpR, we constructed a novel 3-node (3n) circuit (3n1) and observed high-
amplitude oscillations over a broad range of dilution times with the same dependence of amplitude and period on td as 
for the repressilator (Figure 4.3b). In our characterization of the repressilator network and the 3n1 oscillator we found 
dilution rates to be critical for the existence, period and amplitude of oscillations. Protein degradation is similar to 
dilution in that it results in removal of repressor proteins. In order to study the effect of degradation we constructed a 
second 3n network (3n2) using TetR, PhlF and SrpR repressors on linear DNA. One version of the circuit used strong 
ssrA ClpXP degradation tags, while the second used untagged repressors. We observed oscillations for both circuits 
(Figure 4.3c). However, the circuit without ssrA-tag mediated protein degradation exhibited slower oscillations, which 
extended to lower dilution times, showing that protein degradation, just like dilution, affects oscillator function and 
period. Effects of ClpXP-mediated protein degradation, which have been shown to be important for existence and 
frequency of oscillations in vivo96,97, can thus be emulated in a cell-free environment.  
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Theory predicts that ring architectures built from an odd number of repressors oscillate, while even-numbered 
architectures have stable steady states98,99. We experimentally built and tested a 4-node circuit from LacI, TetR, PhlF 
and SrpR on linear DNA. Initial pulses of LacI inducer IPTG or TetR inducer aTc allowed us to switch expression into 
either one of the two stable steady states (Figure 4.3d).  
Encouraged by the robust oscillations observed in the 3n networks, we built two 5-node ring oscillators (5n) to test our 
prototyping environment on a novel synthetic network architecture (Figure 4.3e). Despite their considerable complexity 
both circuits oscillated over a broad range of dilution times with the expected period lengthening, which could be as 
long as 19h. Comparing all ssrA-tagged 3n and 5n ring architectures, we show that the observed periods could be 
accurately predicted for all four networks by computational simulations (Figure 4.3f). Our cell-free framework allows 
testing and characterization of complex networks including verifying networks cloned onto a single plasmid, which is 
the closest approximation to in vivo implementation (Fig. S4.3). 
 
 
 
Figure 4.3 Cell-free prototyping and characterization of novel cyclic negative feedback circuits. 
a, Transfer functions of the repressilator repressor-promoter pairs (top) and TetR homologs (bottom). The TetR 
repressor was tested against two different promoters: the promoter used in the repressilator (top panel) and the J23119-
TetR promoter 95 (bottom panel). Lines are Hill function fits. b, Oscillations of a novel 3-node ring oscillator (3n1) 
constructed on plasmid DNA. c, Two versions of a second 3-node ring oscillator (3n2) on linear DNA were used to study 
the effect of ClpXP degradation on oscillator function. One version was ssrA-tagged on all repressor genes while the 
other version did not carry degradation tags on the repressors. The same reporter with a medium-strength degradation 
tag was used in both versions. d, A 4-node cyclic negative feedback network on linear DNA has two stable steady states 
that depend on the initial conditions. IPTG switched the network into the state where pPhlF was on and pTetR off. An 
initial pulse of aTc resulted in the opposite stable steady state. e, Two 5-node negative feedback architectures oscillated 
with longer periods than our 3-node networks as predicted by simulations (Supplementary Information) (f). 
 
To validate our cell-free approach in vivo we cloned the 3n1 and 3n2 networks onto low-copy plasmids and co-
transformed each with a medium-copy reporter plasmid into lacI- JS006 E. coli80. When tested on a microfluidic device 
(mother machine100), both 3n oscillators showed regular oscillations with periods of 6 ±1 hours for at least 30 hours 
(Figure 4.4a). Both oscillators were surprisingly robust as all cells undergoing healthy cellular division oscillated (n = 
71) (Fig. S4.4). 
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We next tested our 5n oscillators in vivo. Due to loading effects101, 5n1 was not viable when co-transformed with a 
strong reporter. When tested with a low expression strength reporter both 5n oscillators showed robust oscillations that 
were maintained for at least 70 hours, and over 95% of all analyzed traps containing healthy cells oscillated  (n = 104). 
In addition, both 5n networks oscillated with similar periods: 8 hours for 5n1, and 9 hours for 5n2 (Figure 4.4b, Fig. 
S4.4).  
We also tested both 3n oscillators on a CellASIC system, which allows planar single-layer colony formation. In this 
system we observed a striking population level synchronization of daughter cells inheriting the oscillator state from 
their mother cells (Figure 4.4c, Fig. S4.5a). Synchronization was also apparent when using three different fluorescent 
reporters simultaneously (Fig. S4.5b). We did not observe population level synchronization in the original repressilator, 
the OR2* mutant (Fig. S4.5c) nor the 5n networks. Synchronized oscillations were not reported with the original 
repressilator2, and have only been observed in oscillators using intercellular communication102,103. We hypothesize that 
the 3n1 and 3n2 synchronization is due to increased repressor concentrations as compared to the original repressilator 
network (Fig. S4.5d), which increases the inheritance of the period phenotype and minimizes the rapid de-
synchronization expected from stochastic cellular protein fluctuations104. However, a quantitative characterization of the 
synchronization phenotype requires more in depth understanding of stochastic effects in vivo. 
Because cells were synchronized, we were able to analyze the population as a whole to make general conclusions of 
oscillator behavior. We varied dilution time by using different media conditions and media flow rates, and found a 
direct relationship between division times and period, consistent with the in vitro data collected. Oscillation periods of 
the 5n oscillators were also consistent with our in vitro results and showed a similar dependence on doubling time 
(Figure 4.4d). 
Finally, we compared 3n1 and 5n2 with weak and strong reporters in vivo to analyze the effect of protein degradation 
on the oscillator period. We theorized that given a constant concentration of ClpXP, stronger reporters would result in 
more ClpXP loading, thereby slowing the period of oscillation. ClpXP is thought to influence oscillation dynamics in 
vivo in this manner96. We found that in the mother machine, both the period distributions of 3n1 and 5n2 showed this 
characteristic (Figure 4.4e), which reflects our in vitro findings of differential –ssrA tag dependent period length (Figure 
4.3c). 
We demonstrated the utility of our cell-free framework for biological systems engineering and component 
characterization. We observed some differences between the in vitro and cellular environment, particularly in the 
difficulty of predicting cellular toxicity and loading effects of the 5n oscillators in vivo. While more work is necessary 
describing and explaining differences between in vitro and in vivo environments33,34, the observed behavior of complex 
networks in our cell-free environment reflected network behavior in vivo well. The cell-free framework is thus a 
powerful emulator of the cellular environment allowing precise control over experimental conditions and enabling 
studies that are difficult or time consuming to perform in cells. With further developments in cell-free lysate systems 
and supporting technologies, the in vitro approach is posed to play an increasing role in biological systems engineering 
and provides a unique opportunity to design, build, and analyze biological systems. 
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Figure 4.4 Novel 3-node and 5-node ring oscillators in vivo. 
a, Time series traces of 3-node ring oscillators running in E. coli (mother machine). Single trap traces of 3n1 and 3n2 
observed for 36 h in vivo using a strong pPhlF sfGFP-ssrA reporter and a representative image from an “on” and “off” 
state of oscillation. Scale bar: 5 µm. b, Time series traces of 5-node ring oscillators running in E. coli (mother machine). 
Single trap traces of 5n1 and 5n2 observed for 72 h in vivo using a weak pPhlF sfGFP-ssrA reporter. c, 3n1 displays 
phase synchrony in vivo (CellASIC). Time series micrographs of 3n1 under a strong pPhlF sfGFP-ssrA reporter every 
160 min; inset shows individual cells of the initial microcolony. Scale bar: 10 µm and 5 µm (inset). d, Relationship 
between period and division time in vivo. Left, 3n1 in vivo under a strong pPhlF sfGFP-ssrA reporter. The in vitro data is 
shown for comparison. Each point in the in vivo data corresponds to the period and division time from a CellASIC 
experiment run under different media type and flow rates. Right, 5n2 in vivo under a weak pPhlF sfGFP-ssrA reporter. In 
vivo periods determined at 29ºC and 21ºC growth temperature in mother machine experiments. Boxes represent the 
inner quartile range with the median. e, Influence of reporter concentration on oscillation periods by competing for ClpXP 
degradation. Left, with constant amounts of ClpXP the reporter concentration affects repressor degradation and thus 
oscillation period. Histograms of the periods observed with a weak and a strong pPhlF sfGFP-ssrA reporter for both 3n1 
and 5n2 run in the mother machine. Dashed lines indicate the medians. 
 
 
4.3 Methods 
DNA and strain construction 
DNA was constructed using either Golden Gate Assembly or Isothermal Assembly. For linear DNA, all DNA was 
constructed using previously published Rapid Assembly protocols on a “v1-1” vector 33. Linear DNA constructs are 
summarized in Table S4.2. The original repressilator plasmid, pZS1 2 was used as a template for initial characterization 
and for construction of the OR2* mutant. Transfer function plasmids were constructed by Transcriptic, Inc. For other 
plasmids, partial sequences were either obtained from Addgene 95 or synthesized on gBlocks or ssDNA annealed 
oligonucleotides (Integrated DNA Technologies). Specific plasmids required secondary-structure free segments, which 
were designed by R2oDNA 105. JS006 80 was co-transformed with origin-of-replication compatible plasmids to create 
engineered strains. Specifically, negative-feedback oscillator units were cloned onto pSC101* low copy plasmids 
(ampR or kanR), while reporters were cloned onto colE1 medium copy plasmids (kanR or cmR) (Tables S4.3 and 
S4.4). To modulate the reporter copy number, all experiments were conducted below 37°C 106. Strain passage was 
minimized to avoid plasmid deletions due to the recA+ nature of JS006 and the high complexity of oscillator plasmids 
or triple-reporter plasmid. Based on the in vitro and in silico results, we used strong transcriptional and translational 107 
units to maximize gain. 
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TX-TL reactions 
Preparation of TX-TL was conducted as described previously93, but using strain “JS006” co-transformed with Rosetta2 
plasmid and performing a 1:2:1 extract:DNA:buffer ratio.  This resulted in extract “eZS4” with: 8.7 mg/mL protein, 
10.5 mM Mg-glutamate, 100 mM K-glutamate, 0.25 mM DTT, 0.75 mM each amino acid except leucine, 0.63 mM 
leucine, 50 mM HEPES, 1.5 mM ATP and GTP, 0.9 mM CTP and UTP, 0.2  mg/mL tRNA, 0.26 mM CoA, 0.33 mM 
NAD, 0.75 mM cAMP, 0.068 mM folinic acid, 1 mM spermidine, 30 mM 3-PGA, 2% PEG-8000. For experiments 
utilizing linear DNA GamS was added to a final concentration of 3.5 µM33. 
Steady-state reactions 
Experiments were performed in a microfluidic nano-reactor device as described previousely90,93 with some 
modifications to optimize the conditions for the lysate-based TX-TL mix. Reaction temperature was 33°C. Lysate was 
diluted to 2x of the final concentration in 5 mM HEPES 5 mM NaCl buffer (pH 7.2). The reaction buffer mix was 
combined with template DNA and brought to a final concentration of 2x. For a 24 h experiment 30 µl of these stocks 
were prepared. During the experiment, lysate and buffer/DNA solutions were kept in separate tubing feeding onto the 
chip, cooled to approximately 6ºC, and combined on-chip. We ran experiments with dilution rates (µ) between 
approximately 2.8 and 0.5 h-1, which corresponds to dilution times, td = ln(2) µ-1, between 15 and 85 min. These were 
achieved with dilution steps exchanging between 7 and 25% of the reactor volume with time intervals of 7 to 10 min, 
which alternately added fresh lysate stock or fresh buffer/DNA solution into the reactors. Dilution rates were calibrated 
before each experiment. Initial conditions for the limit cycle analysis of the repressilator network were set by adding 
pre-synthesized repressor protein at the beginning of each experiment. For this, CI repressor (together with Citrine 
reporter) and TetR repressor (together with Cerulean reporter) were expressed for 2.5h in batch. On chip the initial 
reaction was mixed to be composed of 25% pre-synthesis reaction and 75% fresh TX-TL mix and repressilator template 
DNA. Then, the experiment was performed at a td of 19.2 ± 0.3 min.  Initial conditions for the 4-node experiment were 
2.5µM aTc or 250µM IPTG, and the experiment was performed at a td of 44.5 ± 0.9 min. DNA template concentrations 
used in steady-state reactions are listed in Table S4.5. Arbitrary fluorescence values were converted to absolute 
concentrations from a calibration using purified Citrine, Cerulean, and mCherry, which were prepared using previously 
published protocols utilizing a His6 purification method followed by size-exclusion chromatography and a Bradford 
assay to determine protein concentration33. 
Transfer function measurement 
Transfer functions of the repressor – promoter pairs were determined in the nano-reactor device at a minimum of two 
different dilution times (Fig. S4.2). All tested promoters were cloned into a plasmid in front of a BCD7 ribosomal 
binding site and the Citrine open reading frame. A non-saturating concentration of 1nM plasmid was used in the 
experiment. The repressors were expressed from linear templates carrying the J23151 promoter and the BCD7 
ribosomal binding site with time-varying concentrations, which were increased from 0 to 2.5nM and decreased back to 
0 during the course of the experiment90. Simultaneously we expressed Cerulean as a reporter for the repressor 
concentration from a linear template at an identical concentration as the repressor template. From the concentration of 
the Citrine reporter we calculated the synthesis rate of the fluorescent protein over time using a model of steady state 
protein synthesis in the nano-reactor device90,  
(1) Pd (t + !t) = Pd (t)+ syn(t) "!t #mat "Pd (t) "!t # dil "Pd (t)  
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(2)    Pf (t + !t) = Pf (t) + mat "Pd (t) " !t # dil "Pf (t)  
where Pd and Pf are dark and fluorescent reporter concentration respectively, t is time, Δt is the time interval between 
dilution steps, dil is the volume fraction replaced per dilution step, which was determined during the calibration of the 
device, and mat is maturation rate of the fluorescent protein. Maturation times of Citrine and Cerulean were determined 
as described previously90 and were 15 ±4 min for Cerulean and 29 ±3 min for Citrine. Dark fluorescent protein was 
calculated from equation (2): 
(3)    Pd (t) = Pf (t + !t) " Pf (t) + dil #Pf (t)mat # !t  
and the synthesis rate was calculated from equation (1): 
(4) syn(t) = Pd (t + !t)" Pd (t)+mat #Pd (t) #!t + dil #Pd (t) . 
We used the sum of measured fluorescent Cerulean concentration and equation (3) for dark Cerulean as a measure of 
the total repressor protein present at any time during the experiment. 
The synthesis rates were normalized to their respective maximal values (vmax) and plotted against the concentration of 
the repressor reporter using only repressor concentrations higher than 1nM. The transfer curves were then fit to a Hill 
function 
(5) y = f (x) = ymin + (1! ymin )
n
KMn
KM + x
n    
where y is the synthesis rate, ymin is the minimum synthesis rate, n is the Hill coefficient and KM is the Michaelis 
Menten constant for half maximal promoter activity. The fitting was performed in Igor Pro using orthogonal distance 
regression with ODRPACK95 assuming a 9% error in the measurements of Citrine and Cerulean fluorescence. 
Vmax measurements 
Relative promoter strengths (vmax values) were determined using the transfer function promoter plasmids. In vitro 
strengths were determined in 5 µl TX-TL reactions at a DNA template concentration of 1nM. Reactions were 
assembled in 384-well plates, overlaid with 35 µl Chill-Out Liquid wax (BioRad) and analyzed using a Biotek 
SynergyMx plate reader set to 33ºC reaction temperature, and reading Citrine fluorescence with Exc:510±9nm and 
Em:540±9nm. For comparison, Citrine fluorescence at 6h was normalized to the value of pLacI. 
In vivo strengths were determined using E. coli JS006 transformed with the same plasmids. Cells were grown at 29ºC in 
MOPS medium supplemented with 0.4% glycerol and 0.2% casaminoacids. For each strain, three independent 
overnight cultures were diluted 1:50 and grown to mid-log phase. They were then diluted to a starting OD600 of 0.15 
into 100 µl growth medium in a 96-well plate and grown in the plate reader at 29ºC with periodic shaking measuring 
Citrine fluorescence. Fluorescence values were normalized to OD resulting in steady state values after 2 h. Average 
steady state values were normalized to pLacI for comparison with the in vitro measurement. 
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In vivo experiments 
Mother machine100 experiments were conducted with custom-made microfluidic chips (mold courtesy of M. Delincé 
and J. McKinney, EPFL). E. coli cells were trapped in channels of 30 µm length, 2 µm width and 1.2 µm height. Before 
loading onto the device, cells were grown from a frozen stock to stationery phase. Cells were then concentrated 10-fold 
and loaded onto the chip. Experiments were performed using LB medium supplemented with 0.075% Tween-20 at a 
flow rate of 400 µl/h. Oscillation traces were collected from single mother machine traps using the background 
subtracted average fluorescence intensity of the entire trap.  
CellASIC experiments were conducted using B04A plates (Merck Millipore, Darmstadt Germany). Flow rates were 
varied between 0.25 psi – 2 psi. Cells were grown from frozen stock in media at running temperature to stationery phase. 
Cells were then diluted 1:100 for 2 hours, and loaded on a equilibrated plate at 1:1000 or less to achieve single-cell 
loading efficiencies per chamber. To vary cellular doubling times, different growth media were used: LB (BD 
Biosciences), M9CA (Sigma Aldrich) with 0.2% glucose, 2xYT (MP Bio), MOPS EZ Rich (Teknova). 
Cells were imaged in time series every 10-20 min using a 100x phase objective minimizing both lamp intensity (12% 
Xcite 120, Excelitas Inc. Waltam MA or 1-2% CoolLED pE-2, Custom interconnected Ltd., UK) and exposure times 
(<500ms) to limit photo-toxicity. 
Analysis of in vivo data 
Images were processed and stitched108, if necessary, using Fiji/ImageJ109. Fluorescence traces of cell populations with 
synchronized oscillations were extracted from CellASIC movies using background corrected mean fluorescence 
intensity from the entire field of view. For cells that were not synchronized over the complete field of view, we tracked 
regions of oscillating sister cells at the edge of the microcolony. We used ImageJ to define polygonal regions around 
those cells and manually shifted the polygonal region to track the front of growing cells. Periods were determined from 
fluorescence traces derived from mother machine and CellASIC movies by measuring the time from one oscillation 
peak to the next peak. Doubling times were estimated by averaging over the doubling times of at least ten individual 
cells. 
Model 
We consider an n-node negative cyclic feedback biocircuit and denote the genes, mRNAs and proteins by G1, G2, …, Gn, 
and M1, M2, …, Mn and P1, P2, …, Pn, respectively. Let ri(t) and pi(t) denote the concentrations of mRNA Mi and protein 
Pi, respectively. For example, the novel 3-node ring oscillator in Figure 4.3b is defined by n = 3, r1(t) = [BetI mRNA], 
r2(t) = [PhlF mRNA], r3(t) = [SrpR mRNA], p1(t) = [BetI protein], p2(t) = [PhlF protein], p3(t) = [SrpR protein]. 
Our mathematical model considers transcription, translation and degradation of mRNA and protein molecules as 
summarized in the box below, where ai and bi represent the degradation rates of Mi and Pi, respectively, and ci and βi are 
the translation and transcription rates. The constants Ki-1 and νi are the Michaelis-Menten constant and the Hill 
coefficient associated with the protein Pi-1 and the corresponding promoter on gene Gi. We hereafter use subscripts 0 
and n+1 as the substitutes of n and 1, respectively, to avoid notational clutter. 
Using the law of mass action and the quasi-steady state approximation, the dynamics of the mRNA and protein 
concentrations can be modeled by the following ordinary differential equations (ODE) 
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!! ! = − !! + ! !! ! + !!! !!!!!!!!!!!! !!!!!!! ! ,  (1)  !! ! = − !! + ! !! ! + !!!! ! , 
where i = 1,2,…, n, and g is the concentration of the circuit plasmid. The constant µ is the dilution rate of mRNA and 
proteins by the microfluidic device. The dilution time of the microfluidic device is defined by 
!! ≔ ln  (2)µμ  .            (2) 
Stoichiometry and reaction rates: 
Description Reaction Reaction rate 
Transcription of Mi !! + !!!! → !! + !!!! +!! !! !!!!!!!!!!!! + !!!!!!  
Translation of Mi !! → !!+!! ci ri 
Degradation of Mi !! → ø ai ri 
Degradation of Pi !! → ø bi pi 
 
The ODE model (1) was numerically simulated using ode45 solver of MATLAB R2013b to obtain qualitative insight 
into the period as well as the oscillatory parameter regime (Figure 4.3f and Fig. S4.1b). The parameters summarized in 
the following table were used for the simulations. 
Parameters used for simulations: 
 Description Parameter value 
ai Degradation rate of mRNAs (min-1) ln(2)/8 (half-life time: 8 minutes) 
bi Degradation rate of proteins (min-1) ln(2)/90 (half-life time: 90 minutes) 
βi 
Transcription rate 
(nM • min-1 • plasmid concentration-1) 0.4 
ci 
Translation rate 
(nM • min-1 • mRNA concentration-1) 0.5 
Ki Michaelis-Menten constant (nM) 5.0 
νi Hill-coefficient 2.0 
 
The plasmid concentration g was set as g = 5.0 nM for Figure 4.3f. The initial concentrations for the simulations were 
r1(0) = 30, p1(0) = 0 and ri(0) = pi(0) = 0 for i = 2, 3,…, n.  
The period of oscillations was calculated based on the autocorrelation of the simulated protein concentration p1(t). More 
specifically, let  
! ! ≔ !! ! + ! !! ! d!!!!! ,          (3) 
where T1 is a positive constant such that p1(t) is steady state at t = T1, and T2 is a sufficiently large constant compared to 
the period of oscillations. The period of oscillations Tperiod was determined by Tperiod = minτ>0 argmaxτR(τ). The 
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simulation result is also consistent with the analytic estimation of the oscillation period in Hori et al. 99 in that the period 
increases monotonically with the dilution time Td. 
The parameter region for oscillations (Fig. S4.1a) was obtained based on the analysis result (Theorem 3) by Hori et al. 
110. Since parameter values do not depend on the subscript i as shown in the parameters table above, we remove the 
subscript i and define a := a1 (= a2 = … an). In the same way, we define b, c, β, K and ν. 
It was shown that the protein concentrations pi (i =1,2,…, n) oscillate if both of the following inequalities are 
satisfied110. ! > ! !,! ,            (4) 
!" > ! !,!!!! !,! !! !!!! !,! ! ! + ! ! + ! ,        (5) 
where 
! !,! ≔ ! ! !"# !! ! !"#! !! !!!!"#! !!!!!"#! !! , and ! ≔ (!!!)(!!!)(!!!!!!)/! . 
To obtain the parameter region in Fig. S4.1a, we substituted n = 3 and the parameters shown in the table above into the 
right-hand side of the inequality condition (5), then we varied Td (= ln(2)/µ) between 5 to 80. The inequality (4) was 
always satisfied for these parameters.  
The parameter region of Fig. S4.1c was obtained by the local stability analysis of the model (1). The previous 
theoretical result 110 showed that the model (1) has a unique equilibrium point and the protein concentrations pi (i = 1,2, 
…, n) show stable oscillations if the Jacobian matrix evaluated at the equilibrium point has an eigenvalue in the open 
right-half complex plane. Based on this result, we computed the Jacobian eigenvalues with varying K3, which we denote 
by KcI, and Td. The values in the parameters table above were used for the other parameters. The plasmid concentration 
was set as g = 5.0 nM in the computation. 
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4.4 Supplementary Information 
 
 
Figure S4.1 Oscillation parameter regime for a 3-node repressilator network in terms of dilution time.  
a, Transcription (TX) and translation (TL) rates supporting oscillations at different dilution times for a 3-node repressilator 
network. b, We experimentally studied the effect of varying transcription rates on the WT repressilator by measuring the 
range of dilution times that supported sustained oscillations. Transcription rates could be rapidly adjusted by varying 
DNA template concentrations of the repressilator plasmid. For different DNA template concentrations, oscillations 
occurred in different ranges of dilution times. Markers at a period of 0 h indicate a stable steady state, and shaded 
regions highlight dilution times that did not support oscillations for a specific DNA template concentration. A simulation of 
the repressilator network produced similar results but did not capture loading effects on the biosynthetic machinery for 
high DNA template concentrations. c, Increasing the KM value of one repressor, as for CI repressor in the OR2* 
repressilator version, reduces the range of dilution rates that support oscillations as indicated by our experimental results 
(Fig. 2c) (see Materials and Methods for details on model). 
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Figure S4.2 Repressor characterization. 
a, Transfer functions of the repressor – promoter pairs were determined using the cell-free framework as described in the 
Methods. Shown are experimental results and analysis using LacI - pLacI(r) as an example. Synthesis rates from the 
promoter of interest could be followed by Citrine fluorescence. Varying repressor template DNA concentration over time 
allowed us to determine synthesis rates at different repressor concentrations. Cerulean was co-expressed with the 
repressor and served as reporter for repressor concentration. Transfer functions were obtained by plotting Citrine 
synthesis rates from highest to lowest repressor concentration (grey shaded area) against total Cerulean concentration 
and were identical for different dilution times set in the nano-reactor device. b, Comparison of relative promoter strengths 
(vmax), determined in vitro and in vivo. pCI(r), pTetR(r), and pLacI(r) are from2; pTetR is from95 and pLacI from111. Error 
bars indicate standard deviations of three replicates. c, Comparison of KM values measured in vitro in this study with KM 
values determined in vivo by Stanton et al.95. KM values were normalized to the KM of TetR. 
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Figure S4.3 Engineering a 5-node negative feedback oscillator using the cell-free framework. 
A novel network architecture, which shows the intended behavior in silico is first assembled on linear DNA using in vitro 
characterized parts. Initial circuit testing on linear DNA is advantageous because: i) linear DNA can be synthesized in a 
few hours, ii) it allows rapid testing of multiple circuit variants, iii) and allows expression strengths of network components 
to be easily tuned by varying their relative concentrations. A functional circuit can then be further characterized to identify 
parameter ranges that support the desired behavior and to experimentally test hypotheses. If an in vivo implementation 
is intended, the cloned plasmids are verified for correct function in vitro before in vivo implementation. 
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Figure S4.4 Robust oscillations of 3-node and 5-node oscillators in vivo. 
3-node (top) and 5-node networks (bottom) oscillate with periods that depend on the network size in vivo. Shown are the 
distributions of observed period lengths with medians indicated by dashed lines. Both 3-node and 5-node networks 
exhibited robust oscillation with all growing cells oscillating for the 3-node networks and more than 95% of growing cells 
oscillating for the 5-node networks (defined as at least two distinct oscillation peaks per trace). Shown are four example 
traces for all oscillators in addition to the ones shown in Fig. 4a-b. Both 3-node networks were analyzed using a strong 
pPhlF sfGFP-ssrA reporter and the two 5-node networks were analyzed using a weak pPhlF sfGFP-ssrA reporter. 
 
 
 
 
 
Figure S4.5 Population level synchronization of 3-node oscillators in vivo. 
a, 3n2 oscillator displays phase synchrony in vivo. 3n2 is run under a strong pPhlF sfGFP-ssrA reporter in the CellASIC 
microfluidic device. b, 3n2 displays phase synchrony observing 3 reporters simultaneously. Reporters are a strong pPhlF 
Citrine-ssrA, pTetR mCherry-ssrA, and pSrpR Cerulean-ssrA. Shown is one oscillation cycle. c, Original repressilator 
and OR2* repressilator do not show phase synchrony. These are run under pTetR(r)-eGFP(ASV) in M9 minimal media; 
oscillations were not supported in LB. All scale bars: 10 µm. 
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Table S4.1 Transfer function parameters. Parameter values of repressor – promoter pairs were determined by fitting 
to the Hill equation as described in the Methods. 
 
Name KM n ymin 
CI – pCI2 5.9 1.9 0.04 
CI – pCI(OR2*)94 103 1.2 0 
LacI – pLacI(r)2 4.1 1.9 0.01 
TetR – pTetR(r)2 2.3 1.2 0.02 
LacI – pLacI111 3.6 1.7 0.01 
SrpR – pSrpR95 86 3.6 0 
PhlF – pPhlF95 79 2 0 
TetR – pTetR95 7.6 0.8 0 
BetI – pBetI95 75.4 1.7 0 
QacR – pQacR95 2.0 1.6 0.02 
Table S4.2. Linear DNAs used in this study. 
 
Name Description Notes 
pJ23119-tetO-BCD2-phlF-
ssrA(LAA) # 3n2, 5n1, 4n  
 pLacI-BCD2-tetR-ssrA(LAA) & 5n1, 4n  
 pLambdaCI-BCD2-lacI-
ssrA(LAA) % 5n1  
 pPhlF-BCD2-srpR-ssrA(LAA) # 3n2, 5n1, 4n  
 pSprR-BCD2-lambdaCI-
ssrA(LAA) # 5n1  
 pSrpR-BCD2-tetR-ssrA(LAA) # 3n2  
 pPhlF-BCD2-srpR # 3n2/no-ssrA 
 pSrpR-BCD2-tetR # 3n2/no-ssrA 
 pTetR-BCD2-phlF # 3n2/no-ssrA 
 pSrpR-BCD2-lacI-ssrA(LAA) # 4n 
 pBetI-BCD7-QacR-ssrA(LAA) # 5n2  
 pPhlF-BCD7-srpR-ssrA(LAA) # 5n2  
 pQacR-BCD7-tetR-ssrA(LAA) # 5n2  
 PSrpR-BCD7-BetI-ssrA(LAA) # 5n2  
 pTetR-BCD7-phlF-ssrA(LAA) # 5n2  
 pJ23151-BCD7-betI $ transfer fxns 
 pJ23151-BCD7-lacI $ transfer fxns 
 pJ23151-BCD7-lambdaCI $ transfer fxns 
 pJ23151-BCD7-phlF $ transfer fxns 
 pJ23151-BCD7-qacR $ transfer fxns 
 pJ23151-BCD7-srpR $ transfer fxns 
 pJ23151-BCD7-tetR $ transfer fxns 
 pLacI-BCD2-sfGFP-ssrA(LAA) & test reporter 
 pLambdaCI-BCD2-sfGFP-
ssrA(LAA) % test reporter 
 pPhlF-BCD2-sfGFP-ssrA(LAA) # test reporter 
 pSrpR-BCD2-sfGFP-ssrA(LAA) # test reporter 
 pTetR-BCD2-sfGFP-ssrA(LAA) # test reporter 
  
# Promoter from Stanton et al. (2014)95 
$ Promoter from Anderson promoter panel 
% Promoter from Elowitz and Leibler (2000)2 
& Promoter from Lutz and Bujard (1997)111 
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Table S4.3. Plasmids used in this study. 
 
Name Description Resistance 
Copy 
number Notes 
pZS1 
% Original 
repressilator plasmid ampR pSC101 
 pZS1 w/ OR2* mutation % ampR pSC101 minimize passages 
pZE21-GFP(AAV) 
% Original 
repressilator reporter 
(pTetO1) kanR colE1 
 
pZE21-eGFP(ASV) 
% pZE21-GFPAAV 
with eGFP replacement kanR colE1 
 
pET21a(+)-Histag-Cerulean 
Expression vector for 
Cerulean purification ampR colE1 c. Transcriptic Inc. 
pET21a(+)-Histag-Citrine 
Expression vector for 
Citrine purification ampR colE1 c. Transcriptic Inc. 
pET21a(+)-Histag-mCherry 
Expression vector for 
mCherry purification ampR colE1 c. Transcriptic Inc. 
pTetR(r)-BCD7-Citrine % transfer fxns kanR pSC101* 
 pTetR-BCD7-Citrine # transfer fxns kanR pSC101* c. Transcriptic Inc. 
pSrpR-BCD7-Citrine # transfer fxns kanR pSC101* c. Transcriptic Inc. 
pQacR-BCD7-Citrine 
# transfer fxns, in vitro 
reporter kanR pSC101* c. Transcriptic Inc. 
pPhlF-BCD7-Citrine  
# transfer fxns, in vitro 
reporter kanR pSC101* c. Transcriptic Inc. 
pLacI-BCD7-Citrine & transfer fxns kanR pSC101* c. Transcriptic Inc. 
pLacI(r)-BCD7-Citrine % transfer fxns kanR pSC101* 
 pCI(OR2*)-BCD7-Citrine * transfer fxns kanR pSC101* 
 pCI-BCD7-Citrine % transfer fxns kanR pSC101* 
 pBetI-BCD7-Citrine # transfer fxns kanR pSC101* c. Transcriptic Inc. 
3n1 oscillator plasmid kanR pSC101* minimize passages 
3n2 oscillator plasmid kanR pSC101* minimize passages 
5n1 oscillator plasmid kanR pSC101* minimize passages 
5n2 oscillator plasmid kanR pSC101* minimize passages 
pBetI-BCD7-phlF-ssrA(LAA) # for building 3n1 ampR pSC101* 
 pBetI-BCD7-qacR-ssrA(LAA) # for building 5n2 ampR pSC101* 
 
pLacO1-BCD7-tetR-ssrA(LAA) & for building 5n1 ampR colE1 
amplify in lacI 
repressor strain 
pLambdaCI-BCD7-lacI-ssrA(LAA) % for building 5n1 ampR colE1 
amplify in lambdaCI 
repressor strain 
pPhlF-BCD7-srpR-ssrA(LAA) 
# for building 3n1, 3n2, 
5n1, 5n2 ampR pSC101* 
 pQacR-BCD7-tetR-ssrA(LAA) # for building 5n2 ampR pSC101* 
 pSrpR-BCD7-betI-ssrA(LAA) # for building 3n1, 5n2 ampR pSC101* 
 pSrpR-BCD7-lambdaCI-ssrA(LAA) # for building 5n1 ampR pSC101* 
 pSrpR-BCD7-tetR-ssrA(LAA) # for building 3n2 ampR pSC101* 
 
pTetR-BCD7-phlF-ssrA(LAA) 
# for building 3n2, 5n1, 
5n2 ampR colE1 
amplify in tetR 
repressor strain 
pPhlF-BCD20-sfGFP-ssrA(LAA) 
# 1 color strong 
reporter used in study ampR colE1 
 
pPhlF-BCD22-sfGFP-ssrA(LAA) 
# 1 color weak reporter 
used in study ampR colE1 
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pPhlF-BCD20-Citrine-ssrA(LAA) 
# for building 3-color 
reporter plasmid ampR colE1 
 
pSrpR-BCD20-Cerulean-ssrA(LAA) 
# for building 3-color 
reporter plasmid ampR colE1 
 
pTetR-BCD20-mCherry-ssrA(LAA) 
# for building 3-color 
reporter plasmid ampR colE1 
 3-color BCD20 reporter, 
pPhlF/pSrpR/pJ23119-tetO 
3 color reporter 
plasmid cmR colE1 minimize passages 
pTetR(r)-Citrine(ASV) % in vitro reporter kanR colE1 
 pTetR(r)-Cerulean(ASV) % in vitro reporter kanR colE1 
 pLacI(r)-mCherry(ASV) % in vitro reporter kanR colE1 
 pLacI(r)-Cerulean(ASV) % in vitro reporter kanR colE1 
 pCI-Citrine-(ASV) % in vitro reporter kanR colE1 
 
pLacI(r)TetR(ASV) 
% for initial conditions 
experiment kanR colE1 
 
pTetR(r)-CI(ASV) 
% for initial conditions 
experiment kanR colE1 
  
# Promoter from Stanton et al. (2014)95 
$ Promoter from Anderson promoter panel 
% Promoter from Elowitz and Leibler (2000)2 
& Promoter from Lutz and Bujard (1997)111  
* Promoter from Rosenfeld et al. (2005)94 
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Table S4.4. Strains used in this study. 
 
Name E. coli type Resistance Notes 
Rosetta2 JS006 cmR 
 pZS1 + pZE21-GFP(AAV) JS006 kanR ampR 
 pET21a(+)-Histag-Citrine BL21-DE3 ampR 
 pET21a(+)-Histag-Cerulean BL21-DE3 ampR 
 pET21a(+)-Histag-mCherry BL21-DE3 ampR 
 3n1 + pPhlF-BCD20-sfGFP-
ssrA(LAA) JS006 kanR ampR minimize passages 
3n1 + pPhlF-BCD22-sfGFP-
ssrA(LAA) JS006 kanR ampR minimize passages 
3n2 + pPhlF-BCD20-sfGFP-
ssrA(LAA) JS006 kanR ampR minimize passages 
3n2 + pPhlF-BCD22-sfGFP-
ssrA(LAA) JS006 kanR ampR minimize passages 
5n1 + pPhlF-BCD20-sfGFP-
ssrA(LAA) JS006 kanR ampR 
cells unhealthy, minimize 
passages 
5n1 + pPhlF-BCD22-sfGFP-
ssrA(LAA) JS006 kanR ampR minimize passages 
5n2 + pPhlF-BCD20-sfGFP-
ssrA(LAA) JS006 kanR ampR minimize passages 
5n2 + pPhlF-BCD22-sfGFP-
ssrA(LAA) JS006 kanR ampR minimize passages 
3n2 + 3-color BCD20 reporter, 
pPhlF/pSrpR/pJ23119-tetO JS006 kanR cmR minimize passages 
pZS1 + pZE21-eGFP(ASV) JS006 kanR ampR 
 pZS1 w/ OR2* mutation +  
pZS21-eGFP(ASV) JS006 kanR ampR 
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Table S5. DNA concentrations used in experiments. 
 
Experiment DNA and concentration Type of DNA 
   
Repressilator 
orig./OR2*, 3color 
Repressilator pZS1 or pZS1 w/ OR2* mutation, 0.5 nM (if 
not otherwise indicated) Plasmid 
 pTetR(r)-Cerulean(ASV), 5 nM Plasmid 
 pLacI(r)-mCherry(ASV), 5 nM Plasmid 
 pCI-Citrine(ASV), 5 nM Plasmid 
  
 Repressilator, initial 
conditions Reaction in nano-reactor:  
 Repressilator pZS1, 5 nM Plasmid 
 pLacI(r)-Cerulean(ASV), 5 nM Plasmid 
 pTetR(r)-Citrine-(ASV), 5 nM Plasmid 
 Pre-synthesis reaction (CI): 
  pTetR(r)-Citrine(ASV), 5 nM Plasmid 
 pTetR(r)-CI(ASV), 5 nM Plasmid 
 Pre-synthesis reaction (TetR):  
 pLacI(r)-Cerulean(ASV), 5 nM Plasmid 
 pLacI(r)TetR(ASV), 5 nM Plasmid 
   
Response curve 
measurements Promoter plasmid: pXXX-BCD7-Citrine, 1 nM Plasmid 
 Repressor template: pJ23151-BCD7-XXX, 0-2.5 nM Linear 
 Repressor reporter: pJ23151-BCD7-Cerulean, 0-2.5 nM Linear 
   
3n1 3n1 oscillator plasmid, 5 nM Plasmid 
 pPhlF-BCD7-Citrine, 2.5 nM Plasmid 
   
3n2 pJ23119-tetO-BCD2-phlF-ssrA(LAA), 1.5 nM Linear 
 pPhlF-BCD2-srpR-ssrA(LAA), 12 nM Linear 
 pSrpR-BCD2-tetR-ssrA(LAA), 24 nM Linear 
 pTetR(r)-Cerulean(ASV), 5 nM Plasmid 
   
3n2/no-ssrA pJ23119-tetO-BCD2-phlF, 1.5 nM Linear 
 pPhlF-BCD2-srpR, 12 nM Linear 
 pSrpR-BCD2-tetR, 24 nM Linear 
 pTetR(r)-Cerulean(ASV), 5 nM Plasmid 
   
4n pJ23119-tetO-BCD2-phlF-ssrA(LAA), 0.75 nM  Linear 
 pLacI-BCD2-tetR-ssrA(LAA), 6 nM Linear 
 pPhlF-BCD2-srpR-ssrA(LAA), 6 nM Linear 
 pSrpR-BCD2-lacI-ssrA(LAA), 12 nM Linear 
 pTetR(r)-Cerulean(ASV), 2.5 nM Plasmid 
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 pLacI(r)-mCherry(ASV), 2.5 nM Plasmid 
 pPhlF-BCD7-Citrine, 2.5 nM Plasmid 
   
5n1 pJ23119-tetO-BCD2-phlF-ssrA(LAA), 1.1 nM Linear 
 pLacI-BCD2-tetR-ssrA(LAA), 16.8 nM Linear 
 pLambdaCI-BCD2-lacI-ssrA(LAA), 1.4 nM Linear 
 pPhlF-BCD2-srpR-ssrA(LAA), 5.6 nM Linear 
 pSprR-BCD2-lambdaCI-ssrA(LAA), 11.2 nM Linear 
 pCI-Citrine(ASV), 3 nM Plasmid 
 pTetR(r)-Cerulean(ASV), 2.5 nM Plasmid 
   
5n1, plasmid DNA 5n1 oscillator plasmid, 5 nM Plasmid 
 pTetR(r)-Cerulean(ASV), 5 nM Plasmid 
 pLacI(r)-mCherry(ASV), 5 nM Plasmid 
 pCI-Citrine(ASV), 5 nM Plasmid 
   
5n2 pBetI-BCD7-QacR-ssrA(LAA), 1 nM Linear 
 pPhlF-BCD7-srpR-ssrA(LAA), 12 nM Linear 
 pQacR-BCD7-tetR-ssrA(LAA), 4 nM Linear 
 pSrpR-BCD7-BetI-ssrA(LAA), 24 nM Linear 
 pTetR-BCD7-phlF-ssrA(LAA), 4 nM Linear 
 pTetR(r)-Cerulean(ASV), 2.5 nM Plasmid 
 pQacR-BCD7-Citrine, 2.5 nM Plasmid 
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Chapter 5 Conclusions and outlook 
The work presented in this thesis shows that cell-free environments are powerful systems to engineer and to 
quantitatively and extensively characterize complex dynamic genetic networks. This section will briefly summarize the 
results, and discuss limitations and future steps. While the research presented here was conducted, enormous progress 
has been made in the field of cell-free synthetic biology, and in this section I will also compare our results and solutions 
with those of others. 
As shown in chapter 2, we designed fluorescent binary FRET probes and a complementary mRNA target sequence to 
measure mRNA concentrations in the defined PURE transcription and translation system, and used them to develop a 
quantitative model of mRNA dynamics. As most regulators used in genetic circuits act on the initiation of transcription, 
it is important to be able to determine mRNA concentrations during TX-TL reactions. We used the probes we 
developed both in batch reactions on the plate reader and in continuous reactions in the microfluidic nano-reactor 
device to understand the kinetics of the TX-TL reaction, and the effects of various genetic regulators. As the probe 
target site is located in the 3’ untranslated region of the mRNA, the target site can be used to measure the concentration 
of any mRNA of interest. The main limitation of our binary probes is that the detection limit for mRNA is relatively 
high (concentrations below 10nM become problematic). To solve this it would theoretically be possible to place 
multiple target sites on one mRNA to increase the signal. We have not tested the binary probes in a lysate-based TX-TL 
system. It is likely that the DNA oligonucleotides would need to be modified to prevent degradation by nucleases for 
use in cell extracts. We observed that binding kinetics can limit the temporal resolution but binding of probes to our 
optimized target site was sufficiently fast for the analysis of mRNA dynamics in the PURE mix. Other methods to 
measure mRNA concentrations in TX-TL reactions were recently developed including molecular beacons11,112 and 
Spinach aptamers113, but these techniques suffer from similar limitations for binding kinetics and detection limits. 
For the successful implementation of complex dynamic networks in TX-TL reactions it is critical to maintain far-from-
equilibrium conditions. As shown in chapter 3, we developed a microfluidic nano-reactor device that allows us to run 
continuous TX-TL reactions for over 30h with transcription and translation rates at constant steady state levels. 
Advantages of this system are the low volume of reagents that is needed for long experiments (about 50µl TX-TL 
reagents for eight simultaneous 30h experiments) and the high level of control over dilution rates and other 
experimental conditions our microfluidic setup allows. In this system we implemented a novel genetic oscillator, which 
was the first oscillating genetic network in a TX-TL reaction. This showed that dynamic genetic networks could indeed 
be implemented and characterized in vitro. The microfluidic chip we developed is very flexible. It can be used to run up 
to eight different experiments at the same time, for example, at different dilution rates or using different template DNAs. 
These parameters can also be changed over the course of an experiment, allowing us to switch DNA concentrations, add 
or remove inducers, and vary dilution rates over time. This flexibility somewhat limits the throughput, however, as the 
fluid manipulations take time and have to be integrated into a program that maintains (close to) continuous reaction 
 
 
86 
conditions. Another limitation is that both TX-TL reagents and DNA flow through the reactor. This makes it necessary 
to prepare rather large amounts of template DNA (either by PCR for linear templates or by extracting plasmids from E. 
coli), which is time consuming and probably as costly as the TX-TL reagents. Roy Bar-Ziv and co-workers have 
developed a different microfluidic device allowing continuous TX-TL reactions and the implementation of dynamic 
genetic networks91. In their device, dilution rates are “hard wired” into the chip by varying capillary lengths connecting 
the reaction chambers to the flow channel, and template DNA is attached to the surface, so that only TX-TL reagents 
need to be flowed. This simpler chip layout would allow a higher throughput but the process of attaching DNA to the 
chip surface is not straightforward.  
Finally, in chapter 4 we demonstrate that cell-free systems can be used for rapid prototyping of dynamic genetic 
networks. Combining custom prepared lysate-based TX-TL reagents with steady state reaction conditions provides the 
opportunity to test networks in a simplified environment, which is however similar enough to in vivo conditions to 
produce relevant results. Using this cell-free framework, we were the first to show the successful implementation of a 
synthetic in vivo oscillator in an in vitro system. We then engineered novel 3-, 4- and 5-node cyclic negative feedback 
architectures using in vitro characterized parts and showed that the novel oscillators functioned similarly in vivo as in 
the cell-free environment. These results indicate that cell-free synthetic biology has the potential to drastically speed up 
design-build-test cycles in biological engineering and enable the quantitative and more complete characterization of 
synthetic and natural networks. The main limitation, when porting networks from the cell-free environment to E. coli, 
were toxic effects that the strongly expressing synthetic circuit imposed on the cells. It would be useful to develop a 
sensor that could indicate strong resource usage already in the cell-free framework. Apart from toxicity, we also 
observed some differences in the behavior of parts and networks between the in vitro and the in vivo system. For 
example, promoter expression strengths did not always compare as had been reported before33,34. Comparing the Kd 
values with the values from in vivo studies, we found that fold-differences were generally higher in vitro than in 
vivo94,95 but the order of repressor strengths was preserved with the exception of QacR, which was a much stronger 
repressor in vitro than in vivo. The majority of in vitro and in vivo results, however, compared surprisingly well. It will 
be interesting to explore why discrepancies exist in some isolated cases, which might reveal new insights about natural 
in vivo processes. With its large volume compared to the volume of an E. coli cell, our reactor-based approach cannot 
capture stochastic processes that influence the behavior of genetic networks in cells. It is, however, also an advantage to 
characterize networks in a more controlled and deterministic system because results are not obscured by noise and the 
variability that is inevitable when working with living cells. 
Further work will be necessary to determine how complex in vitro systems can get and whether fundamental differences 
to cellular systems exist. We have shown that results between in vivo and in vitro systems compare well for molecular 
ring oscillators. If this is true for other genetic network classes remains to be shown. For prototyping applications, it 
would be interesting to increase the throughput of the microfluidic chip, for example to screen large numbers of 
different network variants. To increase throughput, the microfluidic chip could be re-designed to include a larger 
number of reactors, but this would likely decrease flexibility in other experimental parameters. Also, in its current 
implementation our setup only allows interrogation of the reaction by fluorescent readouts. It would however be 
extremely interesting to couple the system with a mass-spectrometer to be able to also quantify metabolites in real-time. 
This would allow the analysis of dynamic metabolic networks coupled to genetic circuits. Expression of metabolic 
pathways could be applied to genomic mining or to develop a metabolism for an artificial cell. In fact, for artificial cell 
research continuous TX-TL reactions could be extremely powerful because they would allow the testing of separate 
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fundamental sub-processes that would have to be implemented in an artificial cell such as DNA replication and 
ribosome biogenesis. To conclude, cell-free, continuous reaction environments will be useful for fundamental research 
in characterizing genetic network architectures, artificial cell research and rapid prototyping to speed up design-build-
test cycles in synthetic biology. 
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